Other JJ O
tumor NN B-Disease
types NNS O
found VBN O
in IN O
BRCA1 NNP O
mutation NN O
/ NNP O
haplotype NN O
carriers NNS O
included VBD O
prostatic JJ B-Disease
, , I-Disease
pancreas NNS I-Disease
, , I-Disease
skin NN I-Disease
, , I-Disease
and CC I-Disease
lung NN I-Disease
cancer NN I-Disease
, , O
a DT O
malignant JJ B-Disease
melanoma NN I-Disease
, , O
an DT O
oligodendroglioma NN B-Disease
, , O
and CC O
a DT O
carcinosarcoma NN B-Disease
. . O

13 CD O
% NN O
for IN O
the DT O
5382insC CD O
mutation NN O
. . O

PAX3 NNP O
codes NNS O
for IN O
a DT O
transcriptional JJ O
regulator NN O
that WDT O
controls VBZ O
developmental JJ O
programs NNS O
, , O
and CC O
FKHR NNP O
codes NNS O
for IN O
a DT O
forkhead JJ O
- : O
winged VBD O
helix NN O
protein NN O
, , O
also RB O
a DT O
likely JJ O
transcription NN O
factor NN O
. . O

The DT O
common JJ O
hereditary JJ O
forms NNS O
of IN O
breast NN B-Disease
cancer NN I-Disease
have VBP O
been VBN O
largely RB O
attributed VBN O
to TO O
the DT O
inheritance NN O
of IN O
mutations NNS O
in IN O
the DT O
BRCA1 NNP O
or CC O
BRCA2 NNP O
genes NNS O
. . O

Hence NNP O
, , O
a DT O
possible JJ O
clinical JJ O
significance NN O
of IN O
the DT O
glycine NN O
into IN O
cysteine NN O
cannot NN O
be VB O
completely RB O
ruled VBN O
out RP O
and CC O
should MD O
be VB O
further RB O
investigated VBN O
. . O

They PRP O
have VBP O
an DT O
increased VBN O
constitutive JJ O
level NN O
of IN O
p21CP1 JJ O
/ NNP O
WAF1 NNP O
. . O

The DT O
instability NN O
of IN O
the DT O
CTG NNP O
repeat NN O
appears VBZ O
to TO O
depend VB O
on IN O
its PRP$ O
size NN O
as RB O
well RB O
as IN O
on IN O
the DT O
sex NN O
of IN O
the DT O
transmitting JJ O
parent NN O
. . O

The DT O
cholesteryl NN O
ester NN O
transfer NN O
protein NN O
( ( O
CETP NNP O
) ) O
mediates VBZ O
the DT O
transfer NN O
of IN O
cholesteryl NN O
esters NNS O
from IN O
HDL NNP O
to TO O
other JJ O
lipoproteins NNS O
and CC O
is VBZ O
a DT O
key JJ O
participant NN O
in IN O
the DT O
reverse NN O
transport NN O
of IN O
cholesterol NN O
from IN O
the DT O
periphery NN O
to TO O
the DT O
liver NN O
. . O

The DT O
study NN O
evaluated VBD O
4 CD O
patients NNS O
with IN O
FMF NNP B-Disease
who WP O
had VBD O
been VBN O
taking VBG O
colchicine NN O
on IN O
a DT O
long JJ O
- : O
term NN O
basis NN O
. . O

The DT O
DM NNP B-Disease
region NN O
of IN O
chromosome NN O
19 CD O
is VBZ O
gene NN O
rich JJ O
, , O
and CC O
it PRP O
is VBZ O
possible JJ O
that IN O
the DT O
repeat NN O
expansion NN O
may MD O
lead VB O
to TO O
dysfunction NN O
of IN O
a DT O
number NN O
of IN O
transcription NN O
units NNS O
in IN O
the DT O
vicinity NN O
, , O
perhaps RB O
as IN O
a DT O
consequence NN O
of IN O
chromatin JJ O
disruption NN O
. . O

11 CD O
times NNS O
greater JJR O
for IN O
BRCA1 NNP O
carriers NNS O
harbouring VBG O
one CD O
or CC O
two CD O
rare JJ O
HRAS1 NNP O
alleles NNS O
, , O
compared VBN O
to TO O
carriers NNS O
with IN O
only JJ O
common JJ O
alleles NNS O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
15 CD O
) ) O
. . O

Yet RB O
, , O
despite IN O
a DT O
large JJ O
international JJ O
effort NN O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
molecular JJ O
mechanisms NNS O
that WDT O
underlie VBP O
this DT O
devastating JJ O
disease NN O
. . O

We PRP O
found VBD O
seven CD O
with IN O
the DT O
LA NNP O
biochemical JJ O
phenotype NN O
, , O
and CC O
all DT O
had VBD O
a DT O
1721C CD O
- : O
- : O
> NN O
T NNP O
transition NN O
in IN O
exon JJ O
7 CD O
in IN O
cis NN O
with IN O
the DT O
N314D NNP O
missense NN O
mutation NN O
. . O

The DT O
remaining VBG O
eight CD O
cases NNS O
( ( O
89 CD O
% NN O
) ) O
of IN O
male NN B-Disease
breast NN I-Disease
cancer NN I-Disease
with IN O
a DT O
family NN O
history NN O
of IN O
breast NN B-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
in IN O
first JJ O
- : O
degree NN O
relatives NNS O
remain VBP O
unaccounted JJ O
for IN O
by IN O
mutations NNS O
in IN O
either CC O
the DT O
BRCA1 NNP O
gene NN O
or CC O
the DT O
BRCA2 NNP O
gene NN O
. . O
. . O

Molecular JJ O
bases NNS O
of IN O
combined JJ B-Disease
subtotal JJ I-Disease
deficiencies NNS I-Disease
of IN I-Disease
C6 NNP I-Disease
and CC I-Disease
C7 NNP I-Disease
: : O
their PRP$ O
effects NNS O
in IN O
combination NN O
with IN O
other JJ O
C6 NNP B-Disease
and CC I-Disease
C7 NNP I-Disease
deficiencies NNS I-Disease
. . O

57 CD O
and CC O
0 CD O
. . O

To TO O
evaluate VB O
this DT O
prevalence NN O
, , O
we PRP O
performed VBD O
biochemical JJ O
analysis NN O
of IN O
very RB O
long RB O
chain NN O
fatty JJ O
acids NNS O
in IN O
14 CD O
male NN O
patients NNS O
( ( O
age NN O
ranging VBG O
from IN O
12 CD O
- : O
45 CD O
yr NN O
at IN O
diagnosis NN O
) ) O
previously RB O
diagnosed VBN O
as IN O
having VBG O
primary JJ O
idiopathic JJ O
adrenocortical JJ B-Disease
insufficiency NN I-Disease
. . O

A DT O
wide JJ O
spectrum NN O
of IN O
mutations NNS O
, , O
ranging VBG O
from IN O
point NN O
mutations NNS O
to TO O
large JJ O
deletions NNS O
, , O
have VBP O
been VBN O
described VBN O
in IN O
the DT O
retinoblastoma NN B-Disease
gene NN O
( ( O
RB1 NNP O
) ) O
. . O

We PRP O
hypothesize VBP O
that IN O
the DT O
patient NN O
is VBZ O
heterozygous JJ O
for IN O
a DT O
complete JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
C9 NNP I-Disease
and CC O
for IN O
a DT O
gene NN O
directing VBG O
hyposynthesis NN O
of IN O
a DT O
defective JJ O
C9 NNP O
. . O

We PRP O
found VBD O
that IN O
in IN O
fractionated JJ O
blood NN O
cell NN O
types NNS O
( ( O
including VBG O
erythroid NN O
, , O
myeloid NN O
, , O
and CC O
lymphoid NN O
cell NN O
lineages NNS O
) ) O
there EX O
was VBD O
a DT O
significant JJ O
excess NN O
of IN O
G6PD NNP O
- : O
normal JJ O
cells NNS O
. . O

By IN O
combining VBG O
these DT O
oligos NNS O
, , O
we PRP O
were VBD O
able JJ O
to TO O
amplify VB O
fragments NNS O
from IN O
100 CD O
to TO O
300 CD O
bases NNS O
( ( O
b NN O
) ) O
from IN O
mouse NN O
liver NN O
cDNA NN O
by IN O
polymerase NN O
chain NN O
reaction NN O
after IN O
reverse JJ O
transcription NN O
( ( O
RT NNP O
- : O
PCR NN O
) ) O
. . O

Although IN O
the DT O
doubly RB O
- : O
deficient NN O
mice NN O
excrete JJ O
adenine NN O
and CC O
its PRP$ O
highly RB O
insoluble JJ O
derivative NN O
, , O
2 CD O
, , O
8 CD O
- : O
dihydroxyadenine NN O
, , O
which WDT O
are VBP O
also RB O
associated VBN O
with IN O
human JJ O
APRT NNP B-Disease
deficiency NN I-Disease
, , O
additional JJ O
abnormalities NNS O
or CC O
any DT O
self JJ O
- : O
injurious JJ O
behavior NN O
were VBD O
not RB O
detected VBN O
. . O

Germline NNP O
VHL NNP B-Disease
gene NN O
mutations NNS O
predispose VBP O
to TO O
the DT O
development NN O
of IN O
retinal JJ B-Disease
, , I-Disease
cerebellar JJ I-Disease
and CC I-Disease
spinal JJ I-Disease
haemangioblastomas NN I-Disease
, , O
renal JJ B-Disease
cell NN I-Disease
carcinoma NN I-Disease
and CC O
phaeochromocytoma NN B-Disease
. . O

A DT O
high JJ O
prevalence NN O
of IN O
two CD O
different JJ O
CETP NNP O
gene NN O
mutations NNS O
( ( O
D442G NNP O
, , O
5 CD O
. . O
1 CD O
% NN O
; : O
intron CC O
14G CD O
A NNP O
, , O
0 CD O
. . O
5 CD O
% NN O
) ) O
, , O
was VBD O
found VBN O
in IN O
3 CD O
, , O
469 CD O
men NNS O
of IN O
Japanese JJ O
ancestry NN O
in IN O
the DT O
Honolulu NNP O
Heart NNP O
Program NNP O
and CC O
mutations NNS O
were VBD O
associated VBN O
with IN O
decreased JJ O
CETP NNP O
( ( O
- : O
35 CD O
% NN O
) ) O
and CC O
increased VBD O
HDL NNP O
chol NN O
levels NNS O
( ( O
+ VB O
10 CD O
% NN O
for IN O
D442G NNP O
) ) O
. . O

The DT O
most RBS O
common JJ O
phenotype NN O
of IN O
ALD NNP B-Disease
is VBZ O
the DT O
cerebral JJ O
form NN O
( ( O
45 CD O
% NN O
) ) O
that WDT O
develops VBZ O
in IN O
boys NNS O
between IN O
5 CD O
- : O
12 CD O
yr NN O
. . O

Cloning VBG O
and CC O
characterization NN O
of IN O
human JJ O
very RB O
- : O
long JJ O
- : O
chain NN O
acyl IN O
- : O
CoA NNP O
dehydrogenase NN O
cDNA NN O
, , O
chromosomal JJ O
assignment NN O
of IN O
the DT O
gene NN O
and CC O
identification NN O
in IN O
four CD O
patients NNS O
of IN O
nine CD O
different JJ O
mutations NNS O
within IN O
the DT O
VLCAD NNP O
gene NN O
. . O

In IN O
7 CD O
of IN O
15 CD O
uncultured JJ O
primary JJ O
human JJ O
breast NN B-Disease
carcinomas NN I-Disease
, , O
intragenic JJ O
deletions NNS O
were VBD O
shown VBN O
in IN O
TSG101 NNP O
genomic JJ O
DNA NNP O
and CC O
transcripts NNS O
by IN O
gel NN O
and CC O
sequence NN O
analysis NN O
, , O
and CC O
mutations NNS O
affecting VBG O
two CD O
TSG101 NNP O
alleles NNS O
were VBD O
identified VBN O
in IN O
four CD O
of IN O
these DT O
cancers NNS B-Disease
. . O

Recently RB O
, , O
a DT O
missense JJ O
mutation NN O
in IN O
transmembrane NN O
domain VBP O
2 CD O
of IN O
CHRNA4 NNP O
was VBD O
found VBN O
to TO O
be VB O
associated VBN O
with IN O
autosomal JJ B-Disease
dominant JJ I-Disease
nocturnal JJ I-Disease
frontal NN I-Disease
lobe NN I-Disease
epilepsy NN I-Disease
in IN O
one CD O
extended VBD O
pedigree NN O
. . O

Identification NN O
and CC O
chromosomal JJ O
localization NN O
of IN O
Atm NNP O
, , O
the DT O
mouse NN O
homolog NN O
of IN O
the DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
gene NN O
. . O

13105 CD O
. . O

The DT O
positions NNS O
of IN O
122 CD O
conserved VBD O
amino NN O
acids NNS O
could MD O
be VB O
determined VBN O
by IN O
multiple JJ O
sequence NN O
alignment NN O
. . O

These DT O
mutants NNS O
provide VBP O
models NNS O
for IN O
elucidating VBG O
the DT O
C2 NNP O
secretory NN O
pathway NN O
. . O
. . O

The DT O
regions NNS O
in IN O
the DT O
mouse NN O
and CC O
rat NN O
were VBD O
homologous JJ O
to TO O
human JJ O
chromosome NN O
11q CD O
. . O

Mutations NNS O
in IN O
the DT O
ARP NNP O
gene NN O
are VBP O
thus RB O
commonly RB O
observed VBN O
in IN O
pancreatic JJ B-Disease
cancer NN I-Disease
, , O
as RB O
well RB O
as IN O
many JJ O
other JJ O
cancers NNS B-Disease
. . O

Microcell NNP O
hybrids NNS O
containing VBG O
only RB O
the DT O
region NN O
10pter CD O
- : O
q11 NN O
were VBD O
suppressed VBN O
for IN O
tumorigenicity NN O
following VBG O
injection NN O
of IN O
microcell NN O
hybrids NNS O
into IN O
nude JJ O
mice NN O
. . O

This DT O
founder NN O
effect NN O
provides VBZ O
a DT O
unique JJ O
opportunity NN O
for IN O
population NN O
- : O
based VBN O
screening NN O
for IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
carriers NNS O
in IN O
a DT O
large JJ O
Jewish NNP O
community NN O
. . O
. . O

Furthermore RB O
, , O
based VBN O
on IN O
our PRP$ O
clinical JJ O
experience NN O
, , O
nursing NN O
appears VBZ O
to TO O
be VB O
safe JJ O
for IN O
lactating VBG O
women NNS O
with IN O
FMF NNP B-Disease
who WP O
continue VBP O
to TO O
take VB O
colchicine NN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
of IN O
a DT O
mutation NN O
at IN O
this DT O
residue NN O
in IN O
either DT O
sporadic JJ B-Disease
tumours NN I-Disease
or CC O
in IN O
the DT O
germline NN O
and CC O
the DT O
first JJ O
report NN O
of IN O
a DT O
germline JJ O
mutation NN O
within IN O
the DT O
tetramerisation NN O
domain NN O
. . O

The DT O
human JJ O
complement NN O
C9 NNP O
gene NN O
: : O
identification NN O
of IN O
two CD O
mutations NNS O
causing VBG O
deficiency NN O
and CC O
revision NN O
of IN O
the DT O
gene NN O
structure NN O
. . O

In IN O
contrast NN O
, , O
a DT O
vector NN O
derived VBN O
from IN O
a DT O
recombinant JJ O
adenovirus NN O
can MD O
restore VB O
10 CD O
% NN O
- : O
80 CD O
% NN O
of IN O
normal JJ O
hepatic JJ O
PAH NNP O
activity NN O
into IN O
PAH NNP B-Disease
- : I-Disease
deficient NN I-Disease
mice NN O
, , O
which WDT O
completely RB O
normalizes VBZ O
serum JJ O
phenylalanine NN O
levels NNS O
. . O

Analysis NN O
of IN O
DMAHP NNP O
expression NN O
in IN O
the DT O
cells NNS O
of IN O
DM NNP B-Disease
patients NNS O
with IN O
loss NN O
of IN O
the DT O
hypersensitive JJ O
site NN O
revealed VBD O
a DT O
two CD O
- : O
to TO O
fourfold VB O
reduction NN O
in IN O
steady JJ O
- : O
state NN O
DMAHP NNP O
transcript NN O
levels NNS O
relative VBP O
to TO O
wild VB O
- : O
type NN O
controls NNS O
. . O

In IN O
addition NN O
to TO O
BRCA1 NNP O
, , O
the DT O
contig NN O
contains VBZ O
two CD O
complete JJ O
genes NNS O
Rho7 NNP O
, , O
a DT O
member NN O
of IN O
the DT O
rho JJ O
family NN O
of IN O
GTP NNP O
binding VBG O
proteins NNS O
, , O
and CC O
VAT1 NNP O
, , O
an DT O
abundant JJ O
membrane NN O
protein NN O
of IN O
cholinergic JJ O
synaptic JJ O
vesicles NNS O
. . O

This DT O
suggests VBZ O
that IN O
any DT O
greater JJR O
amount NN O
of IN O
segregation NN O
distortion NN O
at IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
locus NN O
must MD O
result VB O
from IN O
events NNS O
following VBG O
sperm JJ O
ejaculation NN O
. . O

Transporter NNP O
- : O
facilitated VBD O
uptake NN O
of IN O
serotonin NN O
( ( O
5 CD O
- : O
hydroxytryptamine NN O
or CC O
5 CD O
- : O
HT NN O
) ) O
has VBZ O
been VBN O
implicated VBN O
in IN O
anxiety NN B-Disease
in IN O
humans NNS O
and CC O
animal JJ O
models NNS O
and CC O
is VBZ O
the DT O
site NN O
of IN O
action NN O
of IN O
widely RB O
used VBN O
uptake JJ O
- : O
inhibiting NN O
antidepressant NN O
and CC O
antianxiety NN O
drugs NNS O
. . O

Both DT O
binding VBG O
sites NNS O
are VBP O
preserved VBN O
in IN O
the DT O
mutant NN O
but CC O
have VBP O
decreased VBN O
affinities NNS O
for IN O
iodide NN O
. . O

Deficiency NN B-Disease
of IN I-Disease
terminal JJ I-Disease
complement NN I-Disease
components NNS I-Disease
is VBZ O
generally RB O
associated VBN O
with IN O
recurrent NN O
neisseria NNS B-Disease
infections NNS I-Disease
. . O

The DT O
incidence NN O
of IN O
PAX6 NNP O
mutation NN O
in IN O
patients NNS O
with IN O
simple JJ O
aniridia NN B-Disease
: : O
an DT O
evaluation NN O
of IN O
mutation NN O
detection NN O
in IN O
12 CD O
cases NNS O
. . O

The DT O
product NN O
of IN O
the DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
gene NN O
( ( O
ATM NNP O
) ) O
was VBD O
identified VBN O
by IN O
using VBG O
an DT O
antiserum NN O
developed VBD O
to TO O
a DT O
peptide NN O
corresponding VBG O
to TO O
the DT O
deduced VBN O
amino NN O
acid NN O
sequence NN O
. . O

Colchicine NN O
in IN O
breast NN O
milk NN O
of IN O
patients NNS O
with IN O
familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
. . O

The DT O
present JJ O
study NN O
confirms VBZ O
the DT O
involvement NN O
of IN O
BRCA1 NNP O
in IN O
disease NN O
predisposition NN O
for IN O
a DT O
subset NN O
of IN O
hereditary JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
families NNS O
often RB O
characterized VBN O
by IN O
ovarian JJ B-Disease
cancers NNS I-Disease
. . O

The DT O
Emery NNP B-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
protein NN O
, , O
emerin NN O
, , O
is VBZ O
a DT O
nuclear JJ O
membrane NN O
protein NN O
. . O

Transcription NN O
of IN O
PAX3 NNP O
- : O
FKHR NNP O
is VBZ O
increased VBN O
relative JJ O
to TO O
wild VB O
- : O
type NN O
PAX3 NNP O
by IN O
a DT O
copy NN O
number NN O
- : O
independent JJ O
process NN O
. . O

The DT O
two CD O
genes NNS O
are VBP O
believed VBN O
to TO O
interact VB O
in IN O
a DT O
number NN O
of IN O
pathways NNS O
, , O
including VBG O
regulation NN O
of IN O
DNA NNP O
damage NN O
- : O
induced VBN O
cell NN O
- : O
cycle NN O
checkpoints NNS O
, , O
apoptosis NN O
and CC O
radiation NN O
sensitivity NN O
, , O
and CC O
cellular JJ O
proliferation NN O
. . O

However RB O
, , O
a DT O
single JJ O
mutation NN O
was VBD O
observed VBN O
in IN O
32 CD O
/ JJ O
33 CD O
defective JJ O
ATM NNP O
alleles NNS O
in IN O
Jewish NNP O
A NNP B-Disease
- : I-Disease
T NNP I-Disease
families NNS O
of IN O
North JJ O
African JJ O
origin NN O
, , O
coming VBG O
from IN O
various JJ O
regions NNS O
of IN O
Morocco NNP O
and CC O
Tunisia NNP O
. . O

UKCCCR NNP O
Familial NNP O
Ovarian NNP B-Disease
Cancer NNP I-Disease
Study NNP O
Group NNP O
. . O

To TO O
directly RB O
study VB O
the DT O
role NN O
of IN O
Col3a1 NNP O
in IN O
development NN O
and CC O
disease NN O
, , O
we PRP O
have VBP O
inactivated VBN O
the DT O
Col3a1 NNP O
gene NN O
in IN O
embryonic JJ O
stem NN O
cells NNS O
by IN O
homologous JJ O
recombination NN O
. . O

We PRP O
determined VBD O
48 CD O
amino NN O
acid NN O
residues NNS O
from IN O
five CD O
peptides NNS O
from IN O
the DT O
homogeneous JJ O
monomer NN O
of IN O
homogentisate NN O
1 CD O
, , O
2 CD O
- : O
dioxygenase NN O
( ( O
HGO NNP O
; : O
E NNP O
. . O
C NNP O
. . O
1 CD O
. . O
13 CD O
. . O
11 CD O
. . O
15 CD O
) ) O
of IN O
mouse NN O
liver NN O
. . O

Nine NNP O
different JJ O
germ NNS O
- : O
line NN O
mutations NNS O
in IN O
the DT O
BRCA1 NNP O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
gene NN O
were VBD O
identified VBN O
in IN O
15 CD O
of IN O
47 CD O
kindreds NNS O
from IN O
southern JJ O
Sweden NNP O
, , O
by IN O
use NN O
of IN O
SSCP NNP O
and CC O
heteroduplex JJ O
analysis NN O
of IN O
all DT O
exons NNS O
and CC O
flanking VBG O
intron JJ O
region NN O
and CC O
by IN O
a DT O
protein NN O
- : O
truncation NN O
test NN O
for IN O
exon NN O
11 CD O
, , O
followed VBN O
by IN O
direct JJ O
sequencing NN O
. . O

By IN O
applying VBG O
heteroduplex JJ O
analysis NN O
, , O
nonisotopic JJ O
SSCP NNP O
, , O
and CC O
direct JJ O
sequencing NN O
, , O
we PRP O
detected VBD O
germ JJ O
- : O
line NN O
mutations NNS O
resulting VBG O
in IN O
premature NN O
termination NN O
codons NNS O
or CC O
disruption NN O
of IN O
splice NN O
signals NNS O
in IN O
51 CD O
( ( O
72 CD O
% NN O
) ) O
of IN O
the DT O
71 CD O
patients NNS O
. . O

No DT O
TSG101 NNP O
defects NNS O
were VBD O
found VBN O
in IN O
matched JJ O
normal JJ O
breast NN O
tissue NN O
from IN O
the DT O
breast NN B-Disease
cancer NN I-Disease
patients NNS O
. . O

Many JJ O
human JJ O
tumours NNS B-Disease
have VBP O
length VBN O
alterations NNS O
in IN O
repetitive JJ O
sequence NN O
elements NNS O
. . O

In IN O
vitro JJ O
transfection NN O
studies NNS O
indicated VBD O
that IN O
the DT O
inclusion NN O
of IN O
120 CD O
bp NN O
of IN O
the DT O
5 CD O
UTR NNP O
in IN O
the DT O
cDNA NN O
construct NN O
and CC O
the DT O
presence NN O
of IN O
a DT O
frameshift JJ O
mutation NN O
at IN O
nucleotide JJ O
2349 CD O
prevented JJ O
expression NN O
of IN O
the DT O
HD NNP B-Disease
cDNA NN O
. . O

An DT O
L21 NNP O
ribosomal NN O
protein NN O
pseudogene NN O
is VBZ O
embedded VBN O
in IN O
BRCA1 NNP O
intron NN O
13 CD O
. . O

3 CD O
percent NN O
and CC O
33 CD O
. . O

A DT O
novel NN O
homeodomain NN O
- : O
encoding VBG O
gene NN O
is VBZ O
associated VBN O
with IN O
a DT O
large JJ O
CpG NNP O
island NN O
interrupted VBN O
by IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
unstable JJ O
( ( O
CTG NNP O
) ) O
n RB O
repeat NN O
. . O

The DT O
PAX3 NNP O
- : O
FKHR NNP O
protein NN O
has VBZ O
been VBN O
shown VBN O
to TO O
function VB O
as IN O
a DT O
transcriptional JJ O
activator NN O
. . O

Apopain NNP O
, , O
a DT O
human JJ O
counterpart NN O
of IN O
the DT O
nematode JJ O
cysteine NN O
protease NN O
death NN O
- : O
gene NN O
product NN O
, , O
CED NNP O
- : O
3 CD O
, , O
has VBZ O
a DT O
key JJ O
role NN O
in IN O
proteolytic JJ O
events NNS O
leading VBG O
to TO O
apoptosis NN O
. . O

Somatic JJ O
alterations NNS O
of IN O
the DT O
DPC4 NNP O
gene NN O
in IN O
human JJ O
colorectal NN B-Disease
cancers NNS I-Disease
in IN O
vivo NN O
. . O

To TO O
address VB O
this DT O
issue NN O
we PRP O
characterized VBD O
WASP NNP O
mutations NNS O
in IN O
24 CD O
unrelated JJ O
WAS NNP B-Disease
patients NNS O
, , O
including VBG O
18 CD O
boys NNS O
with IN O
severe JJ O
classical NN O
WAS NNP B-Disease
and CC O
6 CD O
boys NNS O
expressing VBG O
mild JJ O
forms NNS O
of IN O
the DT O
disease NN O
, , O
and CC O
then RB O
examined VBD O
the DT O
degree NN O
of IN O
correlation NN O
of IN O
these DT O
as RB O
well RB O
as IN O
all DT O
previously RB O
published VBN O
WASP NNP O
mutations NNS O
with IN O
disease NN O
severity NN O
. . O

Recent JJ O
work NN O
has VBZ O
identified VBN O
a DT O
mouse NN O
gene NN O
( ( O
tsg101 JJ O
) ) O
whose WP$ O
inactivation NN O
in IN O
fibroblasts NNS O
results NNS O
in IN O
cellular JJ O
transformation NN O
and CC O
the DT O
ability NN O
to TO O
produce VB O
metastatic JJ B-Disease
tumors NNS I-Disease
in IN O
nude JJ O
mice NN O
. . O

There EX O
are VBP O
several JJ O
common JJ O
polymorphisms NNS O
in IN O
the DT O
BRCA1 NNP O
gene NN O
which WDT O
generate VBP O
amino NN O
acid JJ O
substitutions NNS O
. . O

To TO O
determine VB O
the DT O
enzymatic JJ O
activities NNS O
produced VBN O
by IN O
these DT O
mutations NNS O
, , O
we PRP O
constructed VBD O
mutated VBN O
GALC NNP O
cDNAs NN O
and CC O
expressed VBD O
them PRP O
in IN O
COS NNP O
- : O
1 CD O
cells NNS O
. . O

Atm NNP O
- : O
deficient NN O
mice NN O
then RB O
exhibit VBD O
many JJ O
of IN O
the DT O
same JJ O
symptoms NNS O
found VBN O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
patients NNS O
and CC O
in IN O
cells NNS O
derived VBN O
from IN O
them PRP O
. . O

Nonsense NNP O
mutation NN O
in IN O
exon JJ O
3 CD O
of IN O
the DT O
proteolipid JJ O
protein NN O
gene NN O
( ( O
PLP NNP O
) ) O
in IN O
a DT O
family NN O
with IN O
an DT O
unusual JJ O
form NN O
of IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
. . O

Muscles NNS O
from IN O
mature NN O
mice NN O
show NN O
variation NN O
in IN O
fibre JJ O
size NN O
, , O
increased VBD O
fibre JJ B-Disease
degeneration NN I-Disease
and CC O
fibrosis NN B-Disease
. . O

Whereas NNP O
heterozygotes VBZ O
suffer VBP O
from IN O
iris JJ B-Disease
hypoplasia NN I-Disease
, , O
homozygous JJ O
mice NN O
lack NN O
eyes NNS O
and CC O
nasal JJ O
cavities NNS O
and CC O
exhibit NN O
brain NN B-Disease
abnormalities NNS I-Disease
. . O

Homozygous JJ O
Brca1 NNP O
( ( O
5 CD O
- : O
6 CD O
) ) O
mutant NN O
mice NN O
die NN O
before IN O
day NN O
7 CD O
. . O

Molecular JJ O
bases NNS O
of IN O
C7 NNP B-Disease
deficiency NN I-Disease
: : O
three CD O
different JJ O
defects NNS O
. . O

The DT O
significant JJ O
concordance NN O
that IN O
we PRP O
have VBP O
observed VBN O
in IN O
the DT O
degree NN O
of IN O
imbalance NN O
in IN O
the DT O
different JJ O
blood NN O
- : O
cell NN O
lineages VBZ O
indicates VBZ O
that IN O
a DT O
selective JJ O
mechanism NN O
is VBZ O
likely JJ O
to TO O
operate VB O
at IN O
the DT O
level NN O
of IN O
pluripotent JJ O
blood NN O
stem NN O
cells NNS O
. . O

Thus RB O
, , O
we PRP O
screened VBD O
16 CD O
endometrial JJ B-Disease
carcinomas NN I-Disease
with IN O
microsatellite JJ O
instability NN O
for IN O
alterations NNS O
in IN O
FEN1 NNP O
( ( O
the DT O
human JJ O
homolog NN O
of IN O
RTH NNP O
) ) O
and CC O
in IN O
MSH3 NNP O
( ( O
refs VB O
12 CD O
- : O
14 CD O
) ) O
. . O

An DT O
animal JJ O
model NN O
for IN O
Norrie NNP B-Disease
disease NN I-Disease
( ( O
ND NNP B-Disease
) ) O
: : O
gene NN O
targeting NN O
of IN O
the DT O
mouse NN O
ND NNP B-Disease
gene NN O
. . O

The DT O
characteristic JJ O
Duarte NNP O
isoform NN O
is VBZ O
also RB O
associated VBN O
with IN O
a DT O
variant NN O
called VBN O
the DT O
"""" NNP O
Los NNP O
Angeles NNP O
( ( O
LA NNP O
) ) O
phenotype NN O
, , O
"""" NNP O
which WDT O
has VBZ O
increased VBN O
GALT NNP O
enzyme JJ O
activity NN O
. . O

Although IN O
we PRP O
found VBD O
no DT O
FEN1 NNP O
mutations NNS O
, , O
a DT O
frameshift NN O
mutation NN O
in IN O
MSH3 NNP O
was VBD O
observed VBN O
in IN O
an DT O
endometrial JJ B-Disease
carcinoma NN I-Disease
and CC O
in IN O
an DT O
endometrial JJ B-Disease
carcinoma NN I-Disease
cell NN O
line NN O
. . O

Here RB O
, , O
we PRP O
report VBP O
the DT O
identification NN O
and CC O
characterization NN O
of IN O
the DT O
chromosome NN O
3 CD O
- : O
derived VBN O
translocation NN O
partner NN O
gene NN O
, , O
which WDT O
we PRP O
have VBP O
designated VBN O
LPP NNP O
( ( O
lipoma JJ B-Disease
preferred VBN O
partner NN O
gene NN O
) ) O
. . O

The DT O
same JJ O
heterozygous JJ O
T NNP O
- : O
> NN O
C NNP O
transition NN O
at IN O
nt JJ O
8567 CD O
of IN O
the DT O
von NN B-Disease
Willebrand NNP I-Disease
factor NN O
( ( O
vWF NN O
) ) O
transcript NN O
was VBD O
found VBN O
in IN O
two CD O
unrelated JJ O
patients NNS O
with IN O
type JJ B-Disease
IID NNP I-Disease
von NNP I-Disease
Willebrand NNP I-Disease
disease NN I-Disease
, , O
with IN O
no DT O
other JJ O
apparent JJ O
abnormality NN O
. . O

However RB O
, , O
the DT O
overall JJ O
prevalence NN O
of IN O
definite JJ O
CHD NNP B-Disease
was VBD O
21 CD O
% NN O
in IN O
men NNS O
with IN O
mutations NNS O
and CC O
16 CD O
% NN O
in IN O
men NNS O
without IN O
mutations NNS O
. . O

The DT O
low JJ O
incidence NN O
of IN O
somatic JJ O
mutations NNS O
suggests VBZ O
that IN O
BRCA1 NNP O
inactivation NN O
in IN O
sporadic JJ O
tumors NNS B-Disease
occurs VBN O
by IN O
alternative JJ O
mechanisms NNS O
, , O
such JJ O
as IN O
interstitial JJ O
chromosomal JJ O
deletion NN O
or CC O
reduced JJ O
transcription NN O
. . O

Classical JJ O
phenylketonuria NN B-Disease
( ( O
PKU NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
caused VBN O
by IN O
a DT O
deficiency NN B-Disease
of IN I-Disease
hepatic JJ I-Disease
phenylalanine NN I-Disease
hydroxylase NN I-Disease
( ( O
PAH NNP O
) ) O
. . O

In IN O
yeast NN O
, , O
mutations NNS O
in IN O
several JJ O
genes NNS O
, , O
including VBG O
RTH NNP O
and CC O
MSH3 NNP O
, , O
cause NN O
microsatellite JJ O
instability NN O
. . O

The DT O
mutations NNS O
were VBD O
small JJ O
insertions NNS O
and CC O
deletions NNS O
and CC O
point NN O
mutations NNS O
in IN O
roughly RB O
equal JJ O
proportions NNS O
. . O
. . O

Twenty NNP O
- : O
three CD O
families NNS O
were VBD O
identified VBN O
through IN O
two CD O
high JJ O
- : O
risk NN O
breast NN B-Disease
cancer NN I-Disease
research NN O
programs NNS O
. . O

BRCA1 NNP O
is VBZ O
secreted VBN O
and CC O
exhibits JJ O
properties NNS O
of IN O
a DT O
granin NN O
. . O

The DT O
extraembryonic JJ O
region NN O
is VBZ O
abnormal JJ O
, , O
but CC O
aggregation NN O
with IN O
wild JJ O
- : O
type NN O
tetraploid JJ O
embryos NN O
does VBZ O
not RB O
rescue VB O
the DT O
lethality NN O
. . O

Trinucleotide NNP O
repeat NN O
expansion NN O
at IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
locus NN O
reduces VBZ O
expression NN O
of IN O
DMAHP NNP O
. . O

Cleavage NN O
of IN O
huntingtin NN O
by IN O
apopain NN O
, , O
a DT O
proapoptotic JJ O
cysteine NN O
protease NN O
, , O
is VBZ O
modulated VBN O
by IN O
the DT O
polyglutamine NN O
tract NN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
pathogenesis NN O
of IN O
HD NNP B-Disease
is VBZ O
not RB O
mediated VBN O
through IN O
DNA NNP O
- : O
protein NN O
interaction NN O
and CC O
that DT O
presence NN O
of IN O
the DT O
RNA NNP O
transcript NN O
with IN O
an DT O
expanded VBN O
CAG NNP O
repeat NN O
is VBZ O
insufficient JJ O
to TO O
cause VB O
the DT O
disease NN O
. . O

We PRP O
show VBP O
here RB O
that IN O
Brca1 NNP O
+ NNP O
/ NNP O
- : O
mice NN O
are VBP O
normal JJ O
and CC O
fertile JJ O
and CC O
lack JJ O
tumors NNS B-Disease
by IN O
age NN O
eleven JJ O
months NNS O
. . O

The DT O
mouse NN O
WASP NNP O
gene NN O
, , O
the DT O
homolog NN O
of IN O
the DT O
gene NN O
mutated VBN O
in IN O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
, , O
has VBZ O
been VBN O
isolated VBN O
and CC O
sequenced VBN O
. . O
the DT O
predicted JJ O
amino NN O
acid JJ O
sequence NN O
is VBZ O
86 CD O
% NN O
identical JJ O
to TO O
the DT O
human JJ O
WASP NNP O
sequence NN O
. . O

Nucleotide NNP O
sequence NN O
analysis NN O
of IN O
a DT O
composite JJ O
cDNA NN O
of IN O
LPP NNP O
revealed VBD O
an DT O
open JJ O
reading NN O
frame NN O
of IN O
1836 CD O
nucleotides NNS O
encoding VBG O
a DT O
proline NN O
- : O
rich JJ O
protein NN O
containing VBG O
a DT O
leucine JJ O
- : O
zipper NN O
motif NN O
in IN O
its PRP$ O
amino NN O
- : O
terminal JJ O
region NN O
and CC O
three CD O
LIM NNP O
domains VBZ O
in IN O
its PRP$ O
carboxy JJ O
- : O
terminal JJ O
region NN O
. . O

We PRP O
therefore VBP O
conclude VBP O
that IN O
the DT O
HGO NNP O
cDNA NN O
encodes VBZ O
the DT O
gene NN O
responsible JJ O
for IN O
alkaptonuria NN B-Disease
. . O

On IN O
all DT O
D NNP O
- : O
2 CD O
alleles NNS O
N314D NNP O
occurred VBD O
in IN O
cis NN O
with IN O
two CD O
intronic JJ O
sequence NN O
changes NNS O
, , O
on IN O
the DT O
D NNP O
- : O
1 CD O
alleles NNS O
in IN O
cis NN O
with IN O
a DT O
neutral JJ O
mutation NN O
in IN O
exon JJ O
7 CD O
. . O

The DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
, , O
an DT O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
immunodeficiency NN I-Disease
disease NN I-Disease
caused VBN O
by IN O
mutation NN O
in IN O
the DT O
recently RB O
isolated VBN O
gene NN O
encoding VBG O
WAS NNP B-Disease
protein NN O
( ( O
WASP NNP O
) ) O
, , O
is VBZ O
known VBN O
to TO O
be VB O
associated VBN O
with IN O
extensive JJ O
clinical JJ O
heterogeneity NN O
. . O

METHODS NNP O
Clinical NNP O
information NN O
, , O
family NN O
histories NNS O
, , O
and CC O
blood NN O
for IN O
DNA NN O
analysis NN O
were VBD O
obtained VBN O
from IN O
263 CD O
women NNS O
with IN O
breast NN B-Disease
cancer NN I-Disease
. . O

BACKGROUND NNP O
To TO O
define VB O
the DT O
incidence NN O
of IN O
BRCA1 NNP O
mutations NNS O
among IN O
patients NNS O
seen VBN O
in IN O
clinics NNS O
that WDT O
evaluate VBP O
the DT O
risk NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
, , O
we PRP O
analyzed VBD O
DNA NNP O
samples NNS O
from IN O
women NNS O
seen VBN O
in IN O
this DT O
setting NN O
and CC O
constructed VBN O
probability NN O
tables NNS O
to TO O
provide VB O
estimates NNS O
of IN O
the DT O
likelihood NN O
of IN O
finding VBG O
a DT O
BRCA1 NNP O
mutation NN O
in IN O
individual JJ O
families NNS O
. . O

We PRP O
found VBD O
a DT O
significant JJ O
association NN O
of IN O
the DT O
INS NNP O
region NN O
with IN O
IDDM NNP B-Disease
. . O

Screening VBG O
for IN O
ESR NNP O
mutations NNS O
in IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
patients NNS O
. . O

6 CD O
percent NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

Genetic JJ O
linkage NN O
between IN O
SJS NNP B-Disease
and CC O
chromosomal JJ O
region NN O
1q36 CD O
- : O
34 CD O
has VBZ O
been VBN O
observed VBN O
in IN O
several JJ O
families NNS O
, , O
but CC O
the DT O
gene NN O
has VBZ O
not RB O
yet RB O
been VBN O
identified VBN O
. . O

Consistent JJ O
with IN O
cellular JJ O
defects NNS O
of IN O
AT NNP B-Disease
patients NNS O
, , O
the DT O
ATM NNP O
- : O
/ SYM O
- : O
cells NNS O
are VBP O
hypersensitive JJ O
to TO O
gamma VB O
- : O
irradiation NN O
and CC O
defective JJ O
in IN O
cell NN O
- : O
cycle NN O
arrest NN O
following VBG O
radiation NN O
, , O
correlating VBG O
with IN O
a DT O
defective JJ O
up RP O
- : O
regulation NN O
of IN O
p53 NN O
. . O

One CD O
is VBZ O
in IN O
exon JJ O
5 CD O
( ( O
nucleotide JJ O
C566 NNP O
- : O
- : O
> NN O
T NNP O
; : O
Ser189 NNP O
- : O
- : O
> NN O
Phe NNP O
) ) O
of IN O
the DT O
C2Q0 NNP O
gene NN O
linked VBD O
to TO O
the DT O
MHC NNP O
haplotype NN O
A11 NNP O
, , O
B35 NNP O
, , O
DRw1 NNP O
, , O
BFS NNP O
, , O
C4A0B1 NNP O
. . O

We PRP O
have VBP O
therefore RB O
assessed VBN O
the DT O
effect NN O
of IN O
the DT O
VHL NNP O
gene NN O
product NN O
on IN O
VEGF NNP O
expression NN O
. . O

In IN O
order NN O
to TO O
elucidate VB O
the DT O
cellular JJ O
and CC O
molecular JJ O
processes NNS O
which WDT O
are VBP O
involved VBN O
in IN O
Norrie NNP B-Disease
disease NN I-Disease
( ( O
ND NNP B-Disease
) ) O
, , O
we PRP O
have VBP O
used VBN O
gene NN O
targeting VBG O
technology NN O
to TO O
generate VB O
ND NNP B-Disease
mutant JJ O
mice NN O
. . O

Thus RB O
, , O
gene NN O
- : O
specific JJ O
mechanisms NNS O
were VBD O
selected VBN O
to TO O
overexpress VB O
PAX3 NNP O
- : O
FKHR NN O
and CC O
PAX7 NNP O
- : O
FKHR NN O
in IN O
alveolar JJ B-Disease
rhabdomyosarcoma NN I-Disease
, , O
presumably RB O
due JJ O
to TO O
differences NNS O
in IN O
regulation NN O
between IN O
the DT O
wild JJ O
- : O
type NN O
loci NN O
. . O

In IN O
10 CD O
of IN O
these DT O
families NNS O
, , O
all PDT O
the DT O
homozygotes NNS O
have VBP O
a DT O
137 CD O
- : O
bp NN O
insertion NN O
in IN O
their PRP$ O
cDNA NN O
caused VBN O
by IN O
a DT O
point NN O
mutation NN O
in IN O
a DT O
sequence NN O
resembling VBG O
a DT O
splice NN O
- : O
donor NN O
site NN O
. . O

Previous JJ O
investigations NNS O
by IN O
Southern NNP O
blot NN O
hybridization NN O
and CC O
PCR NNP O
fragment VBD O
- : O
length NN O
analysis NN O
had VBD O
revealed VBN O
mutations NNS O
in IN O
48 CD O
patients NNS O
. . O

G6PD NNP O
Malaga NNP O
is VBZ O
associated VBN O
with IN O
enzyme JJ B-Disease
deficiency NN I-Disease
( ( O
class NN O
III NNP O
) ) O
, , O
and CC O
the DT O
enzymic JJ O
properties NNS O
of IN O
G6PD NNP O
Malaga NNP O
and CC O
G6PD NNP O
Santamaria NNP O
are VBP O
quite RB O
similar JJ O
, , O
indicating VBG O
that IN O
in IN O
this DT O
case NN O
the DT O
effects NNS O
of IN O
the DT O
two CD O
mutations NNS O
are VBP O
additive JJ O
rather RB O
than IN O
synergistic JJ O
. . O

In IN O
pedigree JJ O
analyses NNS O
, , O
this DT O
1721C CD O
- : O
- : O
> NN O
T NNP O
transition NN O
segregated VBD O
with IN O
the DT O
LA NNP O
phenotype NN O
of IN O
increased JJ O
GALT NNP O
activity NN O
in IN O
three CD O
different JJ O
biochemical JJ O
phenotypes NNS O
( ( O
LA NNP O
/ NNP O
N NNP O
, , O
LA NNP O
/ NNP O
G NNP O
, , O
and CC O
LA NNP O
/ NNP O
D NNP O
) ) O
. . O

Pediatric NNP B-Disease
alveolar JJ I-Disease
rhabdomyosarcoma NN I-Disease
is VBZ O
characterized VBN O
by IN O
a DT O
chromosomal JJ O
translocation NN O
that WDT O
fuses VBZ O
parts NNS O
of IN O
the DT O
PAX3 NNP O
and CC O
FKHR NNP O
genes NNS O
. . O

The DT O
major JJ O
cause NN O
of IN O
death NN O
of IN O
mutant JJ O
mice NN O
was VBD O
rupture NN O
of IN O
the DT O
major JJ O
blood NN O
vessels NNS O
, , O
similar JJ O
to TO O
patients NNS O
with IN O
type JJ B-Disease
IV NNP I-Disease
Ehlers NNP I-Disease
- : I-Disease
Danlos NNP I-Disease
syndrome NN I-Disease
. . O

Due JJ O
to TO O
strong JJ O
linkage NN O
disequilibrium NN O
, , O
these DT O
four CD O
sites NNS O
generate VBP O
only RB O
three CD O
haplotypes NNS O
with IN O
a DT O
frequency NN O
> $ O
1 CD O
. . O

Western JJ O
blot NN O
analysis NN O
was VBD O
not RB O
sufficiently RB O
sensitive JJ O
to TO O
permit VB O
detection NN O
of IN O
this DT O
molecule NN O
. . O

0 CD O
cM JJ O
distal NN O
to TO O
D9Mit99 NNP O
and CC O
1 CD O
. . O

These DT O
observations NNS O
support VBP O
a DT O
new JJ O
mechanism NN O
for IN O
VHL NNP O
- : O
mediated VBD O
transcriptional JJ O
repression NN O
via IN O
a DT O
direct JJ O
inhibitory NN O
action NN O
on IN O
Sp1 NNP O
and CC O
suggest VBP O
that IN O
loss NN O
of IN O
Sp1 NNP O
inhibition NN O
may MD O
be VB O
important JJ O
in IN O
the DT O
pathogenesis NN O
of IN O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
disease NN I-Disease
and CC O
RCC NNP B-Disease
. . O
. . O

Genetic JJ O
heterogeneity NN O
in IN O
hereditary JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
: : O
role NN O
of IN O
BRCA1 NNP O
and CC O
BRCA2 NNP O
. . O

Defective JJ O
dimerization NN O
of IN O
von JJ B-Disease
Willebrand NNP I-Disease
factor NN O
subunits NNS O
due JJ O
to TO O
a DT O
Cys NNP O
- : O
> NN O
Arg NNP O
mutation NN O
in IN O
type NN B-Disease
IID NNP I-Disease
von NNP I-Disease
Willebrand NNP I-Disease
disease NN I-Disease
. . O

FISH NN O
experiments NNS O
with IN O
the DT O
whole JJ O
murine NN O
cDNA NN O
as IN O
probe NN O
clearly RB O
revealed VBD O
signals NNS O
at IN O
the DT O
human JJ O
chromosomal JJ O
band NN O
3q13 CD O
. . O

Fluorescence NN O
in IN O
situ JJ O
hybridisation NN O
( ( O
FISH NNP O
) ) O
studies NNS O
with IN O
distal JJ O
11p13 CD O
specific JJ O
cosmids NNS O
showed VBD O
that IN O
the DT O
chromosome NN O
11 CD O
breakpoint NN O
lay NN O
between IN O
the DT O
aniridia NN B-Disease
( ( O
PAX6 NNP O
) ) O
locus NN O
and CC O
a DT O
region NN O
approximately RB O
100 CD O
kb NNS O
distal JJ O
to TO O
PAX6 NNP O
defined VBN O
by IN O
the DT O
cosmid NN O
FO2121 NNP O
. . O

Thus RB O
, , O
the DT O
death NN O
of IN O
Brca1 NNP O
( ( O
5 CD O
- : O
6 CD O
) ) O
mutant NN O
embryos NN O
prior RB O
to TO O
gastrulation NN O
may MD O
be VB O
due JJ O
to TO O
a DT O
failure NN O
of IN O
the DT O
proliferative JJ O
burst NN O
required VBN O
for IN O
the DT O
development NN O
of IN O
the DT O
different JJ O
germ NN O
layers NNS O
. . O

In IN O
two CD O
patients NNS O
( ( O
DTD NNP B-Disease
and CC O
AO2 NNP B-Disease
/ NNP O
DTD NNP B-Disease
) ) O
, , O
no DT O
other JJ O
structural JJ O
mutation NN O
was VBD O
found VBN O
, , O
but CC O
polymerase NN O
chain NN O
reaction NN O
amplification NN O
and CC O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
analysis NN O
of IN O
fibroblast NN O
cDNA NN O
showed VBD O
reduced VBN O
mRNA NN O
levels NNS O
of IN O
the DT O
wild JJ O
- : O
type NN O
DTDST NNP O
allele IN O
these DT O
two CD O
patients NNS O
may MD O
be VB O
compound VBN O
heterozygotes NNS O
for IN O
the DT O
"""" NNP O
Finnish NNP O
"""" NNP O
mutation NN O
( ( O
as IN O
yet RB O
uncharacterized VBN O
at IN O
the DT O
DNA NNP O
level NN O
) ) O
, , O
which WDT O
causes VBZ O
reduced JJ O
expression NN O
of IN O
DTDST NNP O
. . O

Subsequent JJ O
molecular JJ O
biology NN O
, , O
biosynthetic JJ O
, , O
and CC O
immunofluorescence NN O
studies NNS O
demonstrated VBD O
that IN O
C2 NNP O
secretion NN O
is VBZ O
impaired VBN O
in IN O
Type NNP B-Disease
II NNP I-Disease
C2 NNP I-Disease
deficiency NN I-Disease
because IN O
of IN O
different JJ O
missense NN O
mutations NNS O
at IN O
highly RB O
conserved VBN O
residues NNS O
in IN O
each DT O
of IN O
the DT O
C2Q0 NNP O
alleles NNS O
. . O

Hereditary JJ B-Disease
hyperparathyroidism NN I-Disease
- : I-Disease
jaw NN I-Disease
tumor NN I-Disease
syndrome NN I-Disease
( ( O
HPT NNP B-Disease
- : I-Disease
JT NN I-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
disease NN I-Disease
( ( O
OMIM NNP O
145001 CD O
) ) O
that WDT O
has VBZ O
recently RB O
been VBN O
mapped VBN O
to TO O
chromosomal VB O
region NN O
1q21 CD O
- : O
q32 NN O
( ( O
HRPT2 NNP O
) ) O
. . O

We PRP O
have VBP O
conducted VBN O
a DT O
large JJ O
- : O
scale NN O
population NN O
study NN O
to TO O
investigate VB O
the DT O
prevalence NN O
of IN O
specific JJ O
BRCA1 NNP O
and CC O
BRCA2 NNP O
mutations NNS O
in IN O
Ashkenazi NNP O
Jewish JJ O
individuals NNS O
who WP O
were VBD O
unselected VBN O
for IN O
breast NN B-Disease
cancer NN I-Disease
. . O

52 CD O
% NN O
for IN O
the DT O
6174delT CD O
mutation NN O
. . O

In IN O
addition NN O
, , O
we PRP O
tested VBD O
genetic JJ O
linkage NN O
to TO O
the DT O
SJS NNP B-Disease
locus NN O
on IN O
chromosome NN O
1 CD O
in IN O
one CD O
family NN O
with IN O
two CD O
affected JJ O
sibs NN O
. . O

We PRP O
have VBP O
searched VBN O
for IN O
genes NNS O
associated VBN O
with IN O
a DT O
CpG NNP O
island NN O
at IN O
the DT O
3 CD O
end NN O
of IN O
DMPK NNP O
. . O

The DT O
pattern NN O
of IN O
hereditary JJ B-Disease
cancer NN I-Disease
in IN O
14 CD O
( ( O
61 CD O
% NN O
) ) O
of IN O
the DT O
23 CD O
families NNS O
studied VBN O
was VBD O
attributed VBN O
to TO O
BRCA1 NNP O
by IN O
a DT O
combination NN O
of IN O
linkage NN O
and CC O
mutation NN O
analyses NNS O
. . O

The DT O
presence NN O
of IN O
the DT O
DTDST NNP O
R279W NNP O
mutation NN O
in IN O
a DT O
total NN O
of IN O
11 CD O
patients NNS O
with IN O
AO2 NNP B-Disease
or CC O
DTD NNP B-Disease
emphasizes VBZ O
the DT O
overlap NN O
between IN O
these DT O
conditions NNS O
. . O

To TO O
study VB O
the DT O
molecular JJ O
genetics NNS O
of IN O
classical JJ B-Disease
and CC I-Disease
Duarte NNP I-Disease
galactosemia NN I-Disease
, , O
we PRP O
analyzed VBD O
the DT O
GALT NNP O
mutations NNS O
in IN O
30 CD O
families NNS O
with IN O
classical JJ B-Disease
galactosemia NN I-Disease
, , O
in IN O
10 CD O
families NNS O
with IN O
the DT O
D NNP O
- : O
2 CD O
variant NN O
and CC O
in IN O
3 CD O
individuals NNS O
carrying VBG O
the DT O
D NNP O
- : O
1 CD O
allele NN O
by IN O
denaturing VBG O
gradient JJ O
gel NN O
electrophoresis NN O
( ( O
DGGE NNP O
) ) O
. . O

We PRP O
conclude VBP O
that DT O
CyS2010 NNP O
is VBZ O
essential JJ O
for IN O
normal JJ O
dimerization NN O
of IN O
vWF NN O
subunits NNS O
through IN O
disulfide JJ O
bonding NN O
of IN O
carboxyl NN O
- : O
terminal NN O
domains NNS O
and CC O
that IN O
a DT O
heterozygous JJ O
mutation NN O
in IN O
the DT O
corresponding JJ O
codon NN O
is VBZ O
responsible JJ O
for IN O
defective JJ O
multimer NN O
formation NN O
in IN O
type NN B-Disease
IID NNP I-Disease
von NNP I-Disease
Willebrand NNP I-Disease
disease NN I-Disease
. . O
. . O

When WRB O
these DT O
data NNS O
were VBD O
combined VBN O
with IN O
the DT O
results NNS O
of IN O
our PRP$ O
previous JJ O
investigations NNS O
, , O
mutations NNS O
were VBD O
identified VBN O
in IN O
a DT O
total NN O
of IN O
99 CD O
( ( O
83 CD O
% NN O
) ) O
of IN O
119 CD O
patients NNS O
. . O

SSCP NNP O
analysis NN O
of IN O
individually RB O
amplified JJ O
exons NNS O
, , O
with IN O
which WDT O
nine CD O
of IN O
the DT O
10 CD O
mutations NNS O
were VBD O
seen VBN O
, , O
was VBD O
the DT O
most RBS O
useful JJ O
detection NN O
method NN O
for IN O
PAX6 NNP O
. . O
. . O

The DT O
variable JJ O
penetrance NN O
of IN O
BRCA1 NNP O
suggests VBZ O
that IN O
other JJ O
genetic JJ O
and CC O
non JJ O
- : O
genetic JJ O
factors NNS O
play VBP O
a DT O
role NN O
in IN O
tumourigenesis NN O
in IN O
these DT O
individuals NNS O
. . O

The DT O
spectrum NN O
comprises VBZ O
15 CD O
% NN O
large JJ O
deletions NNS O
, , O
26 CD O
% NN O
small JJ O
length NN O
alterations NNS O
, , O
and CC O
42 CD O
% NN O
base NN O
substitutions NNS O
. . O

We PRP O
have VBP O
found VBN O
that IN O
both DT O
homodimers NNS O
and CC O
heterodimers NNS O
do VBP O
form VB O
involving VBG O
each DT O
of IN O
the DT O
mutant JJ O
subunits NNS O
tested VBN O
and CC O
that IN O
both DT O
heterodimer NN O
pools NNS O
retain VBP O
substantial JJ O
enzymatic JJ O
activity NN O
. . O

Low JJ O
incidence NN O
of IN O
BRCA2 NNP O
mutations NNS O
in IN O
breast NN B-Disease
carcinoma NN I-Disease
and CC O
other JJ O
cancers NNS B-Disease
. . O

Phenotypic NNP O
and CC O
genotypic VB O
overlap NN O
between IN O
atelosteogenesis NN B-Disease
type NN I-Disease
2 CD I-Disease
and CC O
diastrophic JJ B-Disease
dysplasia NN I-Disease
. . O

ATM NNP O
+ NNP O
/ NNP O
- : O
fibroblasts NNS O
and CC O
thymocytes NNS O
showed VBD O
intermediately RB O
defective JJ O
responses NNS O
to TO O
irradiation VB O
but CC O
no DT O
growth NN O
defect NN O
, , O
suggesting VBG O
that IN O
the DT O
increased JJ O
cancer NN B-Disease
risk NN O
of IN O
AT NNP B-Disease
heterozygotes NNS O
could MD O
be VB O
attributable JJ O
to TO O
poor JJ O
checkpoint NN O
function NN O
. . O
. . O

Using VBG O
Northern NNP O
and CC O
Western NNP O
blot NN O
analysis NN O
to TO O
investigate VB O
the DT O
tissue NN O
specific JJ O
distribution NN O
of IN O
VLCAD NNP O
mRNA NN O
and CC O
protein NN O
in IN O
several JJ O
human JJ O
tissues NNS O
we PRP O
showed VBD O
that IN O
VLCAD NNP O
is VBZ O
most RBS O
abundant JJ O
in IN O
heart NN O
and CC O
skeletal JJ O
muscle NN O
. . O

Twenty NNP O
microsatellite NN O
markers NNS O
in IN O
the DT O
HRPT2 NNP O
region NN O
were VBD O
typed VBN O
, , O
in IN O
addition NN O
to TO O
markers NNS O
in IN O
the DT O
multiple JJ B-Disease
endocrine NN I-Disease
neoplasia NN I-Disease
( ( I-Disease
MEN NNP I-Disease
) ) I-Disease
types VBZ I-Disease
1 CD I-Disease
and CC I-Disease
2 CD I-Disease
regions NNS O
at IN O
11q13 CD O
and CC O
10q11 CD O
. . O

To TO O
answer VB O
these DT O
questions NNS O
, , O
we PRP O
have VBP O
established VBN O
a DT O
yeast NN O
system NN O
for IN O
the DT O
coexpression NN O
of IN O
epitope NN O
- : O
tagged JJ O
alleles NNS O
of IN O
human JJ O
GALT NNP O
and CC O
investigated VBN O
both PDT O
the DT O
extent NN O
of IN O
specific JJ O
GALT NNP O
subunit NN O
interactions NNS O
and CC O
the DT O
activity NN O
of IN O
defined JJ O
heterodimer NN O
pools NNS O
. . O

The DT O
fourth JJ O
patient NN O
carried VBD O
a DT O
compound NN O
heterozygous JJ O
mutation NN O
of IN O
535 CD O
- : O
573del CD O
and CC O
L618S NNP O
. . O

G6PD NNP O
Santamaria NNP O
might MD O
have VB O
been VBN O
produced VBN O
by IN O
recombination NN O
between IN O
G6PD NNP O
A NNP O
and CC O
G6PD NNP O
Malaga NNP O
; : O
however RB O
haplotype NN O
analysis NN O
, , O
including VBG O
the DT O
use NN O
of IN O
a DT O
new JJ O
silent JJ O
polymorphism NN O
, , O
suggests VBZ O
that IN O
the DT O
same JJ O
542 CD O
A NNP O
- : O
- : O
> NN O
T NNP O
mutation NN O
has VBZ O
taken VBN O
place NN O
independently RB O
in IN O
a DT O
G6PD NNP O
B NNP O
gene NN O
to TO O
give VB O
G6PD NNP O
Malaga NNP O
and CC O
in IN O
a DT O
G6PD NNP O
A NNP O
gene NN O
to TO O
give VB O
G6PD NNP O
Santamaria NNP O
. . O

198 CD O
198 CD O
. . O

Using VBG O
reverse JJ O
transcriptase NN O
combined VBN O
with IN O
polymerase NN O
chain NN O
reactions NNS O
in IN O
the DT O
analysis NN O
of IN O
a DT O
number NN O
of IN O
lipoma NN B-Disease
cell NN O
lines NNS O
and CC O
primary JJ B-Disease
lipomas NN I-Disease
, , O
it PRP O
appeared VBD O
that IN O
LPP NNP O
is VBZ O
frequently RB O
rearranged VBN O
also RB O
in IN O
cases NNS O
without IN O
a DT O
cytogenetically RB O
detectable JJ O
involvement NN O
of IN O
3q27 CD O
- : O
q28 NN O
. . O

Mutations NNS O
of IN O
the DT O
BRCA1 NNP O
gone VBN O
in IN O
humans NNS O
are VBP O
associated VBN O
with IN O
predisposition NN O
to TO O
breast VB B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
. . O

Autosomal NNP O
dominant JJ O
primary JJ O
hyperparathyroidism NN B-Disease
and CC I-Disease
jaw JJ I-Disease
tumor NN I-Disease
syndrome NN I-Disease
associated VBN O
with IN O
renal JJ B-Disease
hamartomas NN I-Disease
and CC O
cystic JJ B-Disease
kidney NN I-Disease
disease NN I-Disease
: : O
linkage NN O
to TO O
1q21 CD O
- : O
q32 NN O
and CC O
loss NN O
of IN O
the DT O
wild JJ O
type NN O
allele NN O
in IN O
renal JJ B-Disease
hamartomas NN I-Disease
. . O

Genetic JJ O
bases NNS O
of IN O
human JJ O
complement NN B-Disease
C7 NNP I-Disease
deficiency NN I-Disease
. . O

Other JJ O
codons NNS O
containing VBG O
methylated VBN O
cytosines NNS O
have VBP O
not RB O
been VBN O
reported VBN O
to TO O
be VB O
mutated VBN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
used VBD O
the DT O
sodiumbisulfite JJ O
conversion NN O
method NN O
to TO O
detect VB O
cytosine JJ O
methylation NN O
in IN O
representative JJ O
exons NNS O
of IN O
RB1 NNP O
. . O

D NNP O
- : O
1 CD O
increases NNS O
, , O
whereas NNS O
D NNP O
- : O
2 CD O
decreases NNS O
GALT NNP O
activity NN O
. . O

These DT O
common JJ O
mutations NNS O
have VBP O
an DT O
etiological JJ O
role NN O
in IN O
many JJ O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
cases NNS O
and CC O
provide VB O
the DT O
opportunity NN O
to TO O
examine VB O
genotype JJ O
- : O
phenotype NN O
correlations NNS O
and CC O
genotype JJ O
- : O
environment NN O
interactions NNS O
in IN O
individuals NNS O
with IN O
the DT O
identical JJ O
BRCA1 NNP O
lesion NN O
. . O

However RB O
, , O
a DT O
probable JJ O
germline NN O
mutation NN O
in IN O
a DT O
pancreatic JJ B-Disease
tumour NN I-Disease
cell NN O
line NN O
suggests VBZ O
a DT O
role NN O
for IN O
BRCA2 NNP O
in IN O
susceptibility NN O
to TO O
pancreatic JJ B-Disease
cancer NN I-Disease
. . O
. . O

At IN O
the DT O
cytogenetic JJ O
level NN O
this DT O
region NN O
is VBZ O
frequently RB O
deleted VBN O
in IN O
a DT O
variety NN O
of IN O
different JJ O
solid JJ B-Disease
tumors NNS I-Disease
, , O
although IN O
not RB O
in IN O
pancreatic JJ B-Disease
cancer NN I-Disease
. . O

2 CD O
- : O
p11 NN O
. . O

Using VBG O
a DT O
specific JJ O
radioimmunoassay NN O
, , O
we PRP O
determined VBD O
colchicine JJ O
concentrations NNS O
in IN O
the DT O
serum NN O
and CC O
breast NN O
milk NN O
of IN O
4 CD O
patients NNS O
at IN O
various JJ O
time NN O
points NNS O
, , O
following VBG O
oral JJ O
administration NN O
of IN O
the DT O
drug NN O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
the DT O
ATM NNP O
gene NN O
product NN O
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
a DT O
diverse JJ O
group NN O
of IN O
cellular JJ O
processes NNS O
, , O
including VBG O
meiosis NN O
, , O
the DT O
normal JJ O
growth NN O
of IN O
somatic JJ O
tissues NNS O
, , O
immune NN O
development NN O
, , O
and CC O
tumor NN B-Disease
suppression NN O
. . O
. . O

Definition NN O
of IN O
the DT O
genetic JJ O
events NNS O
that WDT O
trigger VBP O
apoptosis NN O
in IN O
the DT O
prostate NN O
could MD O
provide VB O
important JJ O
insights NNS O
into IN O
critical JJ O
pathways NNS O
in IN O
normal JJ O
development NN O
as RB O
well RB O
as IN O
elucidate NN O
the DT O
perturbations NNS O
of IN O
those DT O
key JJ O
pathways NNS O
in IN O
neoplastic JJ O
transformation NN O
. . O

All PDT O
the DT O
mAbs NN O
recognised VBD O
a DT O
34 CD O
kDa NN O
protein NN O
in IN O
all DT O
tissues NNS O
tested VBN O
, , O
though IN O
minor JJ O
emerin SYM O
- : O
related JJ O
bands NNS O
were VBD O
also RB O
detected VBN O
in IN O
some DT O
tissues NNS O
. . O

BRCA1 NNP O
mutations NNS O
cause VBP O
increased VBN O
risk NN O
for IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
, , O
frequently RB O
of IN O
early JJ O
onset NN O
. . O

The DT O
disease NN O
in IN O
these DT O
two CD O
kindreds NNS O
was VBD O
linked VBN O
to TO O
five CD O
markers NNS O
in IN O
the DT O
1q21 CD O
- : O
q32 NN O
region NN O
( ( O
logarithm JJ O
- : O
of IN O
- : O
odds NNS O
scores VBZ O
3 CD O
. . O
2 CD O
- : O
4 CD O
2 CD O
- : O
4 CD O
. . O
2 CD O
) ) O
, , O
whereas JJ O
linkage NN O
to TO O
the DT O
MEN1 NNP B-Disease
and CC O
MEN2 NNP B-Disease
regions NNS O
was VBD O
excluded VBN O
. . O

Mutations NNS O
have VBP O
been VBN O
found VBN O
throughout IN O
the DT O
gene NN O
; : O
however RB O
, , O
these DT O
genetic JJ O
alterations NNS O
do VBP O
not RB O
appear VB O
to TO O
be VB O
homogeneously RB O
distributed VBN O
. . O

Kniest NNP B-Disease
dysplasia NN I-Disease
is VBZ O
a DT O
severe JJ O
chondrodysplasia NN B-Disease
caused VBN O
by IN O
the DT O
defective JJ B-Disease
formation NN I-Disease
of IN I-Disease
type NN I-Disease
II NNP I-Disease
collagen NN I-Disease
. . O

BRCA1 NNP O
and CC O
BRCA2 NNP O
probably RB O
explain VBP O
the DT O
majority NN O
of IN O
hereditary JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
that WDT O
exists VBZ O
in IN O
the DT O
North JJ O
American JJ O
population NN O
. . O

Mutations NNS O
in IN O
BRCA1 NNP O
account NN O
for IN O
approximately RB O
45 CD O
% NN O
of IN O
familial JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
and CC O
90 CD O
% NN O
of IN O
inherited JJ B-Disease
breast NN I-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
, , O
whereas JJ O
mutations NNS O
in IN O
BRCA2 NNP O
account NN O
for IN O
a DT O
comparable JJ O
percentage NN O
of IN O
inherited JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
cases NNS O
. . O

The DT O
molecular JJ O
basis NN O
of IN O
C7 NNP B-Disease
deficiency NN I-Disease
has VBZ O
been VBN O
investigated VBN O
in IN O
two CD O
Irish JJ O
families NNS O
and CC O
a DT O
number NN O
of IN O
Israeli NNP O
families NNS O
of IN O
Moroccan NNP O
Sephardic NNP O
Jewish NNP O
origin NN O
. . O

Increased VBN O
coronary JJ B-Disease
heart NN I-Disease
disease NN I-Disease
in IN O
Japanese JJ O
- : O
American JJ O
men NNS O
with IN O
mutation NN O
in IN O
the DT O
cholesteryl NN O
ester NN O
transfer NN O
protein NN O
gene NN O
despite IN O
increased VBN O
HDL NNP O
levels NNS O
. . O

The DT O
Rb1 NNP O
gene NN O
has VBZ O
been VBN O
implicated VBN O
with IN O
retinoblastoma NN B-Disease
and CC O
is VBZ O
located VBN O
on IN O
human JJ O
Chromosome NNP O
( ( O
Chr NNP O
) ) O
13q14 CD O
. . O

We PRP O
examined VBD O
galactosylceramidase NN O
( ( O
GALC NNP O
) ) O
cDNA NN O
in IN O
four CD O
Japanese JJ O
patients NNS O
with IN O
adult JJ B-Disease
onset VBN I-Disease
globoid NN I-Disease
cell NN I-Disease
leukodystrophy NN I-Disease
( ( O
Krabbe NNP B-Disease
disease NN I-Disease
; : O
AO NNP B-Disease
- : I-Disease
GLD NN I-Disease
) ) O
by IN O
polymerase NN O
chain NN O
reaction NN O
/ NNP O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
( ( O
PCR NNP O
- : O
SSCP NN O
) ) O
analysis NN O
, , O
subsequent JJ O
sequence NN O
determination NN O
, , O
and CC O
restriction NN O
enzyme FW O
digestion NN O
of IN O
PCR NNP O
products NNS O
, , O
initial JJ O
symptoms NNS O
were VBD O
the DT O
onset NN O
of IN O
slowly RB O
progressive JJ O
spastic JJ B-Disease
paraplegia NN I-Disease
from IN O
the DT O
middle NN O
of IN O
the DT O
second JJ O
decade NN O
, , O
and CC O
all DT O
patients NNS O
had VBD O
diminished VBN B-Disease
GALC NNP I-Disease
activity NN I-Disease
in IN O
their PRP$ O
leukocytes NNS O
. . O

One CD O
clone NN O
from IN O
this DT O
library NN O
contained VBD O
the DT O
complete JJ O
cDNA NN O
- : O
insert NN O
for IN O
HGO NNP O
as IN O
determined VBN O
by IN O
sequencing VBG O
. . O

Somatic JJ O
- : O
cell NN O
selection NN O
is VBZ O
a DT O
major JJ O
determinant NN O
of IN O
the DT O
blood NN O
- : O
cell NN O
phenotype NN O
in IN O
heterozygotes NNS O
for IN O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
mutations NNS O
causing VBG O
severe JJ O
enzyme JJ B-Disease
deficiency NN I-Disease
. . O

We PRP O
have VBP O
analyzed VBN O
the DT O
27 CD O
exons NNS O
and CC O
the DT O
promoter NN O
region NN O
of IN O
the DT O
RB1 NNP O
gene NN O
in IN O
familial JJ B-Disease
or CC I-Disease
sporadic JJ I-Disease
bilateral JJ I-Disease
retinoblastoma NN I-Disease
by IN O
using VBG O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
analysis NN O
. . O

Thus RB O
, , O
the DT O
combination NN O
of IN O
a DT O
unique JJ O
mutation NN O
and CC O
polymorphism NN O
causes NNS O
conformational JJ O
change NN O
in IN O
the DT O
GALC NNP O
enzyme NN O
, , O
resulting VBG O
in IN O
low JJ O
enzymatic JJ O
activity NN O
. . O

The DT O
apparently RB O
healthy JJ O
survival NN O
into IN O
old JJ O
age NN O
of IN O
some DT O
individuals NNS O
with IN O
36 CD O
- : O
39 CD O
repeats NNS O
suggests VBZ O
that IN O
the DT O
HD NNP B-Disease
mutation NN O
may MD O
not RB O
always RB O
be VB O
fully RB O
penetrant JJ O
. . O
. . O

2 CD O
percent NN O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
3 CD O
) ) O
. . O

Over IN O
100 CD O
distinct JJ O
disease NN O
- : O
associated VBN O
mutations NNS O
have VBP O
been VBN O
identified VBN O
in IN O
the DT O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
gene NN O
BRCA1 NNP O
. . O

Individuals NNS O
who WP O
have VBP O
rare JJ O
alleles NNS O
of IN O
the DT O
VNTR NNP O
have VBP O
an DT O
increased VBN O
risk NN O
of IN O
certain JJ O
types NNS O
of IN O
cancers NNS B-Disease
, , O
including VBG O
breast NN B-Disease
cancer NN I-Disease
( ( O
2 CD O
- : O
4 CD O
) ) O
. . O

In IN O
5 CD O
of IN O
14 CD O
patients NNS O
( ( O
35 CD O
% NN O
) ) O
, , O
elevated VBD O
plasma JJ O
concentrations NNS O
of IN O
very RB O
long RB O
chain NN O
fatty JJ O
acids NNS O
were VBD O
detected VBN O
. . O

The DT O
A305E NNP O
missense NN O
mutation NN O
accounted VBD O
for IN O
48 CD O
% NN O
( ( O
24 CD O
/ RB O
50 CD O
) ) O
of IN O
mutant JJ O
chromosomes NNS O
in IN O
patients NNS O
of IN O
western JJ O
European JJ O
descent NN O
, , O
while IN O
the DT O
two CD O
predominant JJ O
Jewish JJ O
mutations NNS O
each DT O
accounted VBD O
for IN O
a DT O
single JJ O
mutant JJ O
chromosome NN O
. . O

In IN O
addition NN O
, , O
somatic JJ O
Inactivation NN O
of IN O
the DT O
VHL NNP B-Disease
gene NN O
is VBZ O
frequent JJ O
in IN O
sporadic JJ B-Disease
renal JJ I-Disease
cell NN I-Disease
carcinoma NN I-Disease
and CC O
haemangioblastoma NN B-Disease
. . O

Here RB O
we PRP O
describe VBP O
a DT O
novel JJ O
protein NN O
that WDT O
interacts VBZ O
in IN O
vivo NN O
with IN O
the DT O
N NNP O
- : O
terminal JJ O
region NN O
of IN O
BRCA1 NNP O
. . O

68 CD O
( ( O
P NNP O
= NNP O
. . O
8 CD O
) ) O
. . O

However RB O
, , O
in IN O
the DT O
229 CD O
female NN O
controls NNS O
in IN O
whom WP O
family NN O
history NN O
of IN O
cancer NN B-Disease
was VBD O
known VBN O
, , O
one CD O
of IN O
two CD O
who WP O
had VBD O
a DT O
sister NN O
with IN O
breast NN B-Disease
cancer NN I-Disease
was VBD O
carrying VBG O
the DT O
variant JJ O
allele NN O
. . O

Difficulties NNS O
in IN O
the DT O
ascertainment NN O
of IN O
C9 NNP B-Disease
deficiency NN I-Disease
: : O
lessons NNS O
to TO O
be VB O
drawn VBN O
from IN O
a DT O
compound NN O
heterozygote NN O
C9 NNP B-Disease
- : I-Disease
deficient NN I-Disease
subject NN O
. . O

Initial JJ O
evaluation NN O
of IN O
the DT O
ATM NNP O
knockout NN O
animals NNS O
indicates VBZ O
that IN O
inactivation NN O
of IN O
the DT O
mouse NN O
ATM NNP O
gene NN O
recreates VBZ O
much RB O
of IN O
the DT O
phenotype NN O
of IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
. . O

Heterogeneity NN O
in IN O
Schwartz NNP B-Disease
- : I-Disease
Jampel NNP I-Disease
chondrodystrophic JJ I-Disease
myotonia NN I-Disease
. . O

The DT O
1721C CD O
- : O
- : O
> NN O
T NNP O
transition NN O
is VBZ O
a DT O
neutral JJ O
polymorphism NN O
for IN O
leucine NN O
at IN O
amino NN O
acid NN O
218 CD O
( ( O
L218L NNP O
) ) O
. . O

Finally RB O
- : O
and CC O
in IN O
contrast NN O
to TO O
prior VB O
predictions NNS O
- : O
atm NN O
and CC O
p53 NN O
do VBP O
not RB O
appear VB O
to TO O
interact VB O
in IN O
acute JJ B-Disease
radiation NN I-Disease
toxicity NN I-Disease
, , O
suggesting VBG O
a DT O
separate JJ O
atm NN O
effector NN O
pathway NN O
for IN O
this DT O
DNA NNP O
damage NN O
response NN O
and CC O
having VBG O
implications NNS O
for IN O
the DT O
prognosis NN O
and CC O
treatment NN O
of IN O
human JJ O
tumours NNS B-Disease
. . O
. . O

This DT O
question NN O
is VBZ O
of IN O
particular JJ O
interest NN O
for IN O
the DT O
human JJ O
enzyme NN O
galactose SYM O
- : O
l NN O
- : O
phosphate NN O
uridylyl JJ O
- : O
transferase NN O
( ( O
GALT NNP O
) ) O
, , O
impairment NN O
of IN O
which WDT O
results NNS O
in IN O
the DT O
inherited JJ B-Disease
metabolic JJ I-Disease
disorder NN I-Disease
galactosemia NN B-Disease
, , O
because IN O
many JJ O
if IN O
not RB O
most JJS O
patients NNS O
studied VBN O
to TO O
date NN O
are VBP O
compound VBN O
heterozygotes NNS O
rather RB O
than IN O
true JJ O
molecular JJ O
homozygotes NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
leukocyte JJ O
DNA NN O
from IN O
143 CD O
patients NNS O
with IN O
familial JJ O
clustering NN O
of IN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
and CC O
tumour VB B-Disease
DNA NN O
from IN O
96 CD O
breast NN B-Disease
carcinomas NN I-Disease
were VBD O
screened VBN O
for IN O
base NN O
mutations NNS O
in IN O
the DT O
estrogen NN O
receptor NN O
gene NN O
( ( O
ESR NNP O
) ) O
. . O

The DT O
set NN O
of IN O
32 CD O
families NNS O
in IN O
which WDT O
no DT O
BRCA1 NNP O
alterations NNS O
were VBD O
detected VBN O
included JJ O
1 CD O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
kindred VBD O
manifesting VBG O
clear JJ O
linkage NN O
to TO O
the DT O
BRCA1 NNP O
region NN O
and CC O
loss NN O
of IN O
the DT O
wild JJ O
- : O
type NN O
chromosome NN O
in IN O
associated JJ O
tumors NNS B-Disease
. . O

390X CD O
+ JJ O
0 CD O
. . O

The DT O
sequence NN O
analysis NN O
provides VBZ O
the DT O
basis NN O
for IN O
a DT O
comprehensive JJ O
mutation NN O
screening NN O
of IN O
CHRNA4 NNP O
in IN O
the DT O
above JJ O
- : O
mentioned VBN O
phenotypes NNS O
and CC O
possibly RB O
in IN O
other JJ O
types NNS O
of IN O
idiopathic JJ B-Disease
epilepsies NNS I-Disease
. . O
. . O

We PRP O
found VBD O
that IN O
a DT O
group NN O
of IN O
patients NNS O
have VBP O
mild VBN O
skeletal JJ O
changes NNS O
which WDT O
may MD O
be VB O
secondary JJ O
consequences NNS O
of IN O
myotonia NN B-Disease
, , O
while IN O
another DT O
group NN O
of IN O
patients NNS O
appear VBP O
to TO O
have VB O
primary JJ O
bone NN B-Disease
dysplasia NN I-Disease
with IN O
myotonia NN B-Disease
. . O

Influence NN O
of IN O
PAX6 NNP O
gene NN O
dosage NN O
on IN O
development NN O
: : O
overexpression NN O
causes VBZ O
severe JJ O
eye NN B-Disease
abnormalities NNS I-Disease
. . O

These DT O
results NNS O
strengthen VBP O
the DT O
contention NN O
that WDT O
simple JJ O
loss NN O
- : O
or CC O
gain VB O
- : O
of IN O
- : O
expression NN O
of IN O
DMPK NNP O
is VBZ O
not RB O
the DT O
only JJ O
crucial JJ O
requirement NN O
for IN O
development NN O
of IN O
the DT O
disease NN O
. . O
. . O

Very RB O
- : O
long JJ O
- : O
chain NN O
acyl IN O
- : O
CoA NNP O
dehydrogenase NN O
( ( O
VLCAD NNP O
) ) O
is VBZ O
one CD O
of IN O
four CD O
straight JJ O
- : O
chain NN O
acyl IN O
- : O
CoA NNP O
dehydrogenase NN O
( ( O
ACD NNP O
) ) O
enzymes NNS O
, , O
which WDT O
are VBP O
all DT O
nuclear JJ O
encoded VBN O
mitochondrial JJ O
flavoproteins NNS O
catalyzing VBG O
the DT O
initial JJ O
step NN O
in IN O
fatty JJ O
acid NN O
beta SYM O
- : O
oxidation NN O
. . O

We PRP O
investigated VBD O
whether IN O
the DT O
expression NN O
of IN O
the DT O
DCC NNP O
protein NN O
in IN O
tumor NN B-Disease
cells NNS O
is VBZ O
a DT O
prognostic JJ O
marker NN O
in IN O
colorectal JJ B-Disease
carcinoma NN I-Disease
. . O

Thus RB O
the DT O
most RBS O
common JJ O
polymorphisms NN O
of IN O
the DT O
BRCA1 NNP O
gene NN O
do VBP O
not RB O
make VB O
a DT O
significant JJ O
contribution NN O
to TO O
breast VB B-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
risk NN O
. . O

Together RB O
, , O
these DT O
results NNS O
demonstrate VBP O
that IN O
CTG NNP O
- : O
repeat NN O
expansions NNS O
can MD O
suppress VB O
local JJ O
gene NN O
expression NN O
and CC O
implicate NN O
DMAHP NNP O
in IN O
DM NNP B-Disease
pathogenesis NN O
. . O

The DT O
predicted JJ O
PTEN NNP O
product NN O
has VBZ O
a DT O
protein NN O
tyrosine NN O
phosphatase NN O
domain NN O
and CC O
extensive JJ O
homology NN O
to TO O
tensin VB O
, , O
a DT O
protein NN O
that WDT O
interacts VBZ O
with IN O
actin JJ O
filaments NNS O
at IN O
focal JJ O
adhesions NNS O
. . O

Targeted VBN O
disruption NN O
of IN O
ATM NNP O
leads VBZ O
to TO O
growth NN B-Disease
retardation NN I-Disease
, , O
chromosomal JJ B-Disease
fragmentation NN I-Disease
during IN I-Disease
meiosis NN I-Disease
, , O
immune JJ B-Disease
defects NNS I-Disease
, , O
and CC O
thymic JJ B-Disease
lymphoma NN I-Disease
. . O

In IN O
case NN O
2 CD O
, , O
a DT O
homozygous JJ O
2 CD O
- : O
bp NN O
deletion NN O
( ( O
2137delTG CD O
/ RB O
2138delGT CD O
/ JJ O
2139delTG CD O
) ) O
caused VBD O
a DT O
frameshift NN O
, , O
generating VBG O
a DT O
premature NN O
termination NN O
codon VBZ O
4 CD O
to TO O
6 CD O
nucleotides NNS O
downstream NN O
. . O

The DT O
ATM NNP O
protein NN O
is VBZ O
a DT O
single JJ O
, , O
high JJ O
- : O
molecular JJ O
weight NN O
protein NN O
predominantly RB O
confined VBN O
to TO O
the DT O
nucleus NN O
of IN O
human JJ O
fibroblasts NNS O
, , O
but CC O
is VBZ O
present JJ O
in IN O
both DT O
nuclear JJ O
and CC O
microsomal JJ O
fractions NNS O
from IN O
human JJ O
lymphoblast NN O
cells NNS O
and CC O
peripheral JJ O
blood NN O
lymphocytes NNS O
. . O

We PRP O
report VBP O
a DT O
novel JJ O
missense NN O
change NN O
in IN O
BRCA1 NNP O
, , O
2640 CD O
C NNP O
- : O
- : O
> NN O
T NNP O
( ( O
R841W NNP O
) ) O
, , O
found VBN O
in IN O
3 CD O
cases NNS O
from IN O
a DT O
subject JJ O
group NN O
of IN O
305 CD O
breast NN B-Disease
and CC I-Disease
79 CD I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
cases NNS O
from IN O
Orange NNP O
County NNP O
, , O
CA NNP O
. . O

The DT O
Cox NNP O
proportional JJ O
- : O
hazards NNS O
model NN O
was VBD O
used VBN O
to TO O
adjust VB O
for IN O
covariates NNS O
including VBG O
age NN O
, , O
sex NN O
, , O
tumor NN B-Disease
site NN O
, , O
degree NN O
of IN O
tumor NN B-Disease
differentiation NN O
, , O
and CC O
use NN O
of IN O
adjuvant JJ O
therapy NN O
. . O

5 CD O
is VBZ O
detected VBN O
in IN O
any DT O
of IN O
the DT O
models NNS O
. . O

The DT O
Duarte NNP O
biochemical JJ O
phenotype NN O
has VBZ O
a DT O
molecular JJ O
genotype NN O
of IN O
N314D NNP O
/ NNP O
N314D NNP O
. . O

Allele NNP O
- : O
specific JJ O
analysis NN O
of IN O
DMAHP NNP O
expression NN O
showed VBD O
that IN O
steady JJ O
- : O
state NN O
transcript NN O
levels NNS O
from IN O
the DT O
expanded VBN O
allele NN O
were VBD O
greatly RB O
reduced VBN O
in IN O
comparison NN O
to TO O
those DT O
from IN O
the DT O
wild JJ O
- : O
type NN O
allele NN O
. . O

The DT O
hybrid JJ O
PAX3 NNP O
- : O
FKHR NNP O
fusion NN O
protein NN O
of IN O
alveolar JJ B-Disease
rhabdomyosarcoma NN I-Disease
transforms NNS O
fibroblasts NNS O
in IN O
culture NN O
. . O

A DT O
distinct JJ O
intronic JJ O
nucleotide NN O
sequence NN O
, , O
known VBN O
as IN O
the DT O
branchpoint NN O
region NN O
, , O
plays VBZ O
a DT O
central JJ O
role NN O
in IN O
this DT O
process NN O
. . O

Finally RB O
, , O
this DT O
report NN O
provides VBZ O
a DT O
widely RB O
applicable JJ O
strategy NN O
which WDT O
ensures VBZ O
fast RB O
and CC O
effective JJ O
screening NN O
for IN O
intronic JJ O
defects NNS O
that WDT O
underlie VBP O
differential JJ O
gene NN O
expression NN O
. . O
. . O

Insect NNP O
cells NNS O
infected VBN O
with IN O
recombinant JJ O
baculovirus NN O
expressing VBG O
normal JJ O
vWF JJ O
sequence NN O
secreted VBD O
a DT O
disulfide NN O
linked VBN O
dimeric JJ O
molecule NN O
with IN O
an DT O
apparent JJ O
molecular JJ O
mass NN O
of IN O
150 CD O
kDa NNS O
before IN O
reduction NN O
, , O
yielding VBG O
a DT O
single JJ O
band NN O
of IN O
80 CD O
kDa NNS O
after IN O
disulfide JJ O
bond NN O
reduction NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
have VBP O
observed VBN O
mutations NNS O
involving VBG O
codon NN O
50 CD O
in IN O
11 CD O
of IN O
37 CD O
pancreatic JJ B-Disease
tumors NNS I-Disease
. . O

DGGE NNP O
detected VBD O
59 CD O
of IN O
the DT O
60 CD O
classical JJ O
galactosemia NN B-Disease
alleles NNS O
. . O

A DT O
sex NN O
- : O
dependent JJ O
penetrance NN O
of IN O
primary JJ B-Disease
HPT NNP I-Disease
, , O
resulting VBG O
in IN O
predominantly RB O
male JJ O
- : O
affected JJ O
cases NNS O
was VBD O
evident JJ O
in IN O
the DT O
two CD O
families NNS O
. . O

The DT O
( ( O
CTG NNP O
) ) O
n FW O
repeat NN O
is VBZ O
polymorphic JJ O
and CC O
varies NNS O
in IN O
size NN O
between IN O
5 CD O
and CC O
37 CD O
repeats NNS O
in IN O
unaffected JJ O
individuals NNS O
whereas VBP O
in IN O
affected JJ O
patients NNS O
there EX O
are VBP O
between IN O
50 CD O
and CC O
4 CD O
, , O
0 CD O
CTGs NNP O
. . O

9 CD O
and CC O
8 CD O
. . O

Characterisation NN O
of IN O
the DT O
expression NN O
of IN O
this DT O
gene NN O
in IN O
patient JJ O
tissues NNS O
has VBZ O
thus RB O
far RB O
generated JJ O
conflicting VBG O
data NNS O
on IN O
alterations NNS O
in IN O
the DT O
steady JJ O
state NN O
levels NNS O
of IN O
DMPK NNP O
mRNA NN O
, , O
and CC O
on IN O
the DT O
final JJ O
DMPK NNP O
protein NN O
levels NNS O
in IN O
the DT O
presence NN O
of IN O
the DT O
expansion NN O
. . O

We PRP O
also RB O
show VBP O
that IN O
a DT O
processed JJ O
pseudogene NN O
of IN O
the DT O
acidic JJ O
ribosomal JJ O
phosphoprotein NN O
P1 NNP O
( ( O
ARPP1 NNP O
) ) O
is VBZ O
inserted VBN O
directly RB O
upstream JJ O
of IN O
pseudo JJ O
- : O
BRCA1 NNP O
exon VBZ O
1A CD O
. . O

Expression NN O
of IN O
the DT O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
disease VB I-Disease
tumour NN I-Disease
suppressor NN O
gene NN O
during IN O
human JJ O
embryogenesis NN O
. . O

No DT O
recombinations NNS O
were VBD O
found VBN O
among IN O
the DT O
Atm NNP O
, , O
Npat NNP O
, , O
Acat1 NNP O
, , O
and CC O
D9Mit6 NNP O
loci NN O
, , O
and CC O
these DT O
loci NNS O
were VBD O
mapped VBN O
2 CD O
. . O

The DT O
majority NN O
of IN O
mutant JJ O
mice NNS O
rapidly RB O
develop VBP O
thymic JJ B-Disease
lymphomas NN I-Disease
and CC O
die NN O
before IN O
4 CD O
months NNS O
of IN O
age NN O
. . O

We PRP O
therefore RB O
investigated VBD O
the DT O
expression NN O
of IN O
VHL NNP B-Disease
mRNA NN O
during IN O
human JJ O
embryogenesis NN O
by IN O
in IN O
situ JJ O
hybridization NN O
studies NNS O
at IN O
4 CD O
, , O
6 CD O
and CC O
10 CD O
weeks NNS O
post NN O
conception NN O
. . O

CONCLUSIONS NNP O
SJS NNP B-Disease
is VBZ O
clinically RB O
and CC O
radiologically RB O
heterogeneous JJ O
. . O

In IN O
vitro JJ O
expression NN O
of IN O
mutant JJ O
cDNA NN O
clones NNS O
demonstrated VBD O
that IN O
all DT O
of IN O
these DT O
mutations NNS O
led VBD O
to TO O
a DT O
deficiency NN B-Disease
of IN I-Disease
ASPA NNP I-Disease
and CC O
should MD O
therefore VB O
result NN O
in IN O
Canavan NNP B-Disease
disease NN I-Disease
. . O
. . O

We PRP O
also RB O
suggest VBP O
that IN O
C9 NNP B-Disease
deficiency NN I-Disease
may MD O
be VB O
more JJR O
common JJ O
among IN O
Caucasians NNPS O
than IN O
has VBZ O
been VBN O
reported VBN O
. . O
. . O

Abnormal NNP O
myotonic JJ B-Disease
dystrophy NN I-Disease
protein NN O
kinase NN O
levels NNS O
produce VBP O
only RB O
mild JJ O
myopathy NNS B-Disease
in IN O
mice NN O
. . O

The DT O
conservation NN O
of IN O
the DT O
Rb1 NNP O
gene NN O
in IN O
higher JJR O
primates NNS O
at IN O
the DT O
corresponding JJ O
equivalent JJ O
chromosome NN O
locus NN O
( ( O
14q14 CD O
) ) O
of IN O
the DT O
human NN O
may MD O
serve VB O
as IN O
a DT O
phylogenetic JJ O
marker NN O
to TO O
further JJ O
trace NN O
the DT O
evolutionary JJ O
pathway NN O
of IN O
human JJ O
descent NN O
. . O

Atm NNP O
- : O
deficient NN O
fibroblasts NNS O
grow VBP O
poorly RB O
in IN O
culture NN O
and CC O
display VB O
a DT O
high JJ O
level NN O
of IN O
double JJ O
- : O
stranded VBD O
chromosome NN O
breaks NNS O
. . O

We PRP O
describe VBP O
the DT O
proportion NN O
of IN O
hereditary JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
explained VBN O
by IN O
BRCA1 NNP O
or CC O
BRCA2 NNP O
in IN O
a DT O
sample NN O
of IN O
North JJ O
American JJ O
hereditary NN B-Disease
breast NN I-Disease
cancers NNS I-Disease
and CC O
assess VB O
the DT O
evidence NN O
for IN O
additional JJ O
susceptibility NN O
genes NNS O
that WDT O
may MD O
confer VB O
hereditary JJ B-Disease
breast NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
risk NN O
. . O

The DT O
age NN O
of IN O
cancer NN B-Disease
onset NN O
was VBD O
not RB O
always RB O
distinct VBP O
from IN O
typical JJ O
sporadic JJ O
cases NNS O
. . O

One CD O
patient NN O
was VBD O
found VBN O
to TO O
have VB O
no DT O
alternative JJ O
pathway NN O
activity NN O
but CC O
a DT O
low JJ O
normal JJ O
classical JJ O
pathway NN O
. . O

Only RB O
one CD O
of IN O
the DT O
two CD O
male NN B-Disease
breast NN I-Disease
cancer NN I-Disease
patients NNS O
carrying VBG O
a DT O
BRCA2 NNP O
mutation NN O
had VBD O
a DT O
family NN O
history NN O
of IN O
cancer NN B-Disease
, , O
with IN O
one CD O
case NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
in IN O
a DT O
first JJ O
- : O
degree NN O
relative NN O
. . O

A DT O
distinct JJ O
feature NN O
of IN O
the DT O
mouse NN O
gene NN O
is VBZ O
an DT O
expanded JJ O
polymorphic JJ O
GGA NNP O
trinucleotide NN O
repeat NN O
that WDT O
codes VBZ O
for IN O
polyglycine NN O
and CC O
varies NNS O
from IN O
15 CD O
to TO O
17 CD O
triplets NNS O
in IN O
different JJ O
Mus NNP O
musculus NN O
strains NNS O
. . O

Pleiotropic NNP O
defects NNS O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
protein SYM O
- : O
deficient NN O
mice NN O
. . O

This DT O
implies VBZ O
a DT O
smaller JJR O
deletion NN O
limited VBD O
to TO O
the DT O
PWS NNP B-Disease
critical JJ O
region NN O
. . O

Eight CD O
single JJ O
nucleotide RB O
polymorphisms NNS O
were VBD O
also RB O
readily RB O
detected VBN O
. . O

RESULTS VB O
The DT O
expression NN O
of IN O
DCC NNP O
was VBD O
a DT O
strong JJ O
positive JJ O
predictive JJ O
factor NN O
for IN O
survival NN O
in IN O
both DT O
stage NN B-Disease
II NNP I-Disease
and CC I-Disease
stage NN I-Disease
III NNP I-Disease
colorectal JJ I-Disease
carcinomas NN I-Disease
. . O

We PRP O
next RB O
demonstrated VBD O
in IN O
coimmunoprecipitates NNS O
that IN O
VHL NNP O
and CC O
Sp1 NNP O
were VBD O
part NN O
of IN O
the DT O
same JJ O
complex NN O
and CC O
, , O
by IN O
using VBG O
a DT O
glutathione NN O
- : O
S NNP O
- : O
transferase NN O
- : O
VHL NNP O
fusion NN O
protein NN O
and CC O
purified JJ O
Sp1 NNP O
, , O
that IN O
VHL NNP O
and CC O
Sp1 NNP O
directly RB O
interact VBP O
. . O

However RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
the DT O
Arg356 NNP O
allele NN O
may MD O
have VB O
a DT O
different JJ O
genotype NN O
distribution NN O
in IN O
breast NN B-Disease
cancer NN I-Disease
patients NNS O
from IN O
that DT O
in IN O
controls NNS O
( ( O
Arg356 NNP O
homozygotes NNS O
are VBP O
more RBR O
frequent JJ O
in IN O
the DT O
control NN O
groups NNS O
, , O
P NNP O
= VBZ O
0 CD O
. . O
1 CD O
) ) O
, , O
indicating VBG O
that IN O
it PRP O
may MD O
be VB O
protective JJ O
against IN O
breast NN B-Disease
cancer NN I-Disease
. . O

Moderate NNP O
intergenerational JJ O
and CC O
somatic JJ O
instability NN O
of IN O
a DT O
55 CD O
- : O
CTG NN O
repeat NN O
in IN O
transgenic JJ O
mice NN O
. . O

Exon NNP O
PCR NNP O
and CC O
sequencing VBG O
revealed VBD O
a DT O
heterozygous JJ O
point NN O
mutation NN O
at IN O
the DT O
3 CD O
splice NN O
acceptor NN O
site NN O
of IN O
intron NN O
1 CD O
in IN O
one CD O
Irish JJ O
family NN O
. . O

Immune NNP B-Disease
defects NNS I-Disease
also RB O
are VBP O
evident JJ O
in IN O
ATM NNP O
- : O
/ SYM O
- : O
mice NN O
, , O
including VBG O
reduced JJ O
numbers NNS O
of IN O
B220 NNP O
+ NNP O
CD43 NNP O
- : O
pre NN O
- : O
B NNP O
cells NNS O
, , O
thymocytes NNS O
, , O
and CC O
peripheral JJ O
T NNP O
cells NNS O
, , O
as RB O
well RB O
as IN O
functional JJ O
impairment NN O
of IN O
T NNP O
- : O
cell NN O
- : O
dependent NN O
immune JJ O
responses NNS O
. . O

With IN O
respect NN O
to TO O
their PRP$ O
roles NNS O
in IN O
apoptosis NN O
, , O
loss NN O
of IN O
atm NN O
rendered VBN O
thymocytes VBZ O
only RB O
partly RB O
resistant JJ O
to TO O
irradiation VB O
- : O
induced JJ O
apoptosis NN O
, , O
whereas JJ O
additional JJ O
loss NN O
of IN O
p53 NN O
engendered VBD O
complete JJ O
resistance NN O
. . O

Neither CC O
a DT O
cytogenetically RB O
detectable JJ O
15q12 CD O
deletion NN O
nor CC O
a DT O
deletion NN O
for IN O
the DT O
D15S11 NNP O
, , O
D15S10 NNP O
, , O
and CC O
GABRB3 NNP O
cosmid VBP O
probes NNS O
were VBD O
found VBN O
in IN O
either DT O
patient NN O
. . O

The DT O
TSG101 NNP O
tumor NN B-Disease
susceptibility NN O
gene NN O
is VBZ O
located VBN O
in IN O
chromosome NN O
11 CD O
band NN O
p15 NN O
and CC O
is VBZ O
mutated VBN O
in IN O
human JJ O
breast NN B-Disease
cancer NN I-Disease
. . O

By IN O
performing VBG O
in IN O
vitro JJ O
expression NN O
of IN O
LCAT NNP O
minigenes NNS O
and CC O
reverse VB O
transcriptase NN O
PCR NNP O
on IN O
mRNA NN O
isolated VBN O
from IN O
leukocytes NNS O
of IN O
the DT O
patient NN O
, , O
this DT O
gene NN O
defect NN O
was VBD O
shown VBN O
to TO O
cause VB O
a DT O
null JJ O
allele NN O
as IN O
the DT O
result NN O
of IN O
complete JJ O
intron NN O
retention NN O
. . O

Abnormal NNP O
CAG NNP O
expansions NNS O
in IN O
the DT O
IT NNP O
- : O
15 CD O
gene NN O
are VBP O
associated VBN O
with IN O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
. . O

The DT O
nonsense JJ O
mutation NN O
, , O
which WDT O
is VBZ O
in IN O
exon JJ O
3B CD O
, , O
should MD O
block VB O
the DT O
synthesis NN O
of IN O
normal JJ O
PLP NNP O
but CC O
spare JJ O
DM20 NNP O
, , O
the DT O
isoform NN O
whose WP$ O
persistence NN O
has VBZ O
been VBN O
associated VBN O
with IN O
mild JJ O
forms NNS O
of IN O
PLP NNP B-Disease
- : I-Disease
associated JJ I-Disease
disease NN I-Disease
in IN O
both DT O
humans NNS O
and CC O
mice NN O
. . O
. . O

Plasma NNP O
high JJ O
density NN O
lipoprotein NN O
( ( O
HDL NNP O
) ) O
levels NNS O
are VBP O
strongly RB O
genetically RB O
determined VBN O
and CC O
show VB O
a DT O
general JJ O
inverse NN O
relationship NN O
with IN O
coronary JJ B-Disease
heart NN I-Disease
disease NN I-Disease
( ( O
CHD NNP B-Disease
) ) O
. . O

BRCA1 NNP O
intron NN O
lengths NNS O
range VBP O
in IN O
size NN O
from IN O
403 CD O
bp NN O
to TO O
9 CD O
. . O

By IN O
using VBG O
this DT O
approach NN O
, , O
we PRP O
were VBD O
able JJ O
to TO O
identify VB O
mutation NN O
in IN O
22 CD O
new JJ O
patients NNS O
, , O
but CC O
the DT O
overall JJ O
efficiency NN O
of IN O
the DT O
procedure NN O
when WRB O
we PRP O
used VBD O
a DT O
single JJ O
- : O
pass NN O
regimen NN O
was VBD O
only RB O
48 CD O
% NN O
. . O

Comparative JJ O
genome NN O
mapping NN O
of IN O
the DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
region NN O
in IN O
mouse NN O
, , O
rat NN O
, , O
and CC O
Syrian JJ O
hamster NN O
. . O

A DT O
tentative JJ O
clinico NN O
- : O
radiological JJ O
classification NN O
can MD O
be VB O
useful JJ O
for IN O
the DT O
characterization NN O
of IN O
patients NNS O
and CC O
the DT O
development NN O
of IN O
genotype NN O
- : O
phenotype NN O
correlations NNS O
. . O
. . O

The DT O
BARD1 NNP O
/ NNP O
BRCA1 NNP O
interaction NN O
is VBZ O
disrupted VBN O
by IN O
BRCA1 NNP O
missense NN O
mutations NNS O
that WDT O
segregate VBP O
with IN O
breast NN B-Disease
cancer NN I-Disease
susceptibility NN O
, , O
indicating VBG O
that IN O
BARD1 NNP O
may MD O
be VB O
involved VBN O
in IN O
mediating VBG O
tumour JJ B-Disease
suppression NN O
by IN O
BRCA1 NNP O
. . O
. . O

METHODS NNP O
. . O

In IN O
contrast NN O
, , O
where WRB O
the DT O
C7 NNP O
genes NNS O
are VBP O
both DT O
defective JJ O
( ( O
but CC O
still RB O
partially RB O
functional JJ O
) ) O
, , O
there EX O
may MD O
be VB O
a DT O
profound JJ O
deficit NN O
of IN O
circulating VBG O
C7 NNP O
because IN O
there EX O
is VBZ O
ample JJ O
C6 NNP O
to TO O
produce VB O
C56 NNP O
and CC O
consume VB O
the DT O
already RB O
small JJ O
amount NN O
of IN O
C7 NNP O
. . O

Apoptosis NN O
has VBZ O
recently RB O
been VBN O
recognized VBN O
as IN O
a DT O
mode NN O
of IN O
cell NN O
death NN O
in IN O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
. . O

A DT O
striking JJ O
clustering NN O
of IN O
missense JJ O
mutations NNS O
in IN O
the DT O
first JJ O
four CD O
exons NNS O
contrasted VBN O
with IN O
a DT O
random JJ O
distribution NN O
of IN O
nonsense JJ O
mutations NNS O
. . O

The DT O
mouse NN O
homolog NN O
of IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome VBP I-Disease
protein NN O
( ( O
WASP NNP O
) ) O
gene NN O
is VBZ O
highly RB O
conserved VBN O
and CC O
maps NNS O
near IN O
the DT O
scurfy NN O
( ( O
sf NN O
) ) O
mutation NN O
on IN O
the DT O
X NNP O
chromosome NN O
. . O

PTEN NNP O
, , O
a DT O
putative JJ O
protein NN O
tyrosine NN O
phosphatase NN O
gene NN O
mutated VBN O
in IN O
human JJ O
brain NN B-Disease
, , I-Disease
breast NN I-Disease
, , I-Disease
and CC I-Disease
prostate NN I-Disease
cancer NN I-Disease
. . O

The DT O
24 CD O
exons NNS O
of IN O
BRCA1 NNP O
span VBP O
an DT O
81 CD O
- : O
kb NN O
region NN O
that WDT O
has VBZ O
an DT O
unusually RB O
high JJ O
density NN O
of IN O
Alu NNP O
repetitive JJ O
DNA NNP O
( ( O
41 CD O
. . O
5 CD O
% NN O
) ) O
, , O
but CC O
relatively RB O
low JJ O
density NN O
( ( O
4 CD O
. . O
8 CD O
% NN O
) ) O
of IN O
other JJ O
repetitive JJ O
sequences NNS O
. . O

The DT O
Schwartz NNP B-Disease
- : I-Disease
Jampel NNP I-Disease
syndrome NN I-Disease
( ( O
SJS NNP B-Disease
; : O
chondrodystrophic JJ B-Disease
myotonia NN I-Disease
; : O
McK NNP O
255 CD O
, , O
800 CD O
) ) O
is VBZ O
a DT O
recessively RB B-Disease
inherited JJ I-Disease
condition NN I-Disease
defined VBN O
by IN O
myotonia NN B-Disease
, , O
short JJ B-Disease
stature NN I-Disease
, , O
and CC O
bone NN B-Disease
dysplasia NN I-Disease
. . O

We PRP O
report VBP O
about IN O
Dr NNP O
. . O
Kniest NNP O
, , O
who WP O
first RB O
described VBD O
the DT O
condition NN O
in IN O
1952 CD O
, , O
and CC O
his PRP$ O
patient NN O
, , O
who WP O
, , O
at IN O
the DT O
age NN O
of IN O
50 CD O
years NNS O
is VBZ O
severely RB B-Disease
handicapped VBN I-Disease
with IN O
short JJ B-Disease
stature NN I-Disease
, , O
restricted VBD B-Disease
joint JJ I-Disease
mobility NN I-Disease
, , O
and CC O
blindness NN B-Disease
but CC O
is VBZ O
mentally RB O
alert JJ O
and CC O
leads VBZ O
an DT O
active JJ O
life NN O
. . O

As IN O
a DT O
regulated JJ O
secretory NN O
protein NN O
, , O
BRCA1 NNP O
appears VBZ O
to TO O
function VB O
by IN O
a DT O
mechanism NN O
not RB O
previously RB O
described VBN O
for IN O
tumour NN B-Disease
suppressor NN O
gene NN O
products NNS O
. . O
. . O

This DT O
difference NN O
in IN O
mutation NN O
sites NNS O
may MD O
affect VB O
the DT O
clinical JJ O
features NNS O
of IN O
GLD NNP B-Disease
. . O

Chromosomal JJ O
translocations NNS O
identified VBN O
in IN O
hematopoietic JJ B-Disease
and CC I-Disease
solid JJ I-Disease
tumors NNS I-Disease
result VBP O
in IN O
deregulated JJ O
expression NN O
of IN O
protooncogenes NNS O
or CC O
creation NN O
of IN O
chimeric JJ O
proteins NNS O
with IN O
tumorigenic JJ O
potential NN O
. . O

In IN O
the DT O
four CD O
polymorphic JJ O
variants NNS O
that WDT O
have VBP O
two CD O
point NN O
mutations NNS O
, , O
one CD O
of IN O
the DT O
mutations NNS O
is VBZ O
always RB O
376 CD O
A NNP O
- : O
- : O
> NN O
G NNP O
( ( O
126 CD O
Asn NNP O
- : O
- : O
> JJ O
Asp NNP O
) ) O
, , O
which WDT O
on IN O
its PRP$ O
own JJ O
gives VBZ O
rise NN O
to TO O
the DT O
nondeficient JJ O
polymorphic JJ O
variant NN O
, , O
G6PD NNP O
A NNP O
. . O

Mutations NNS O
associated VBN O
with IN O
variant JJ O
phenotypes NNS O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
. . O

Its PRP$ O
levels NNS O
ranged VBN O
between IN O
1 CD O
. . O

Here RB O
we PRP O
report VBP O
that IN O
the DT O
hypersensitive JJ O
site NN O
contains VBZ O
an DT O
enhancer NN O
element NN O
that WDT O
regulates VBZ O
transcription NN O
of IN O
the DT O
adjacent JJ O
DMAHP NNP O
homeobox NN O
gene NN O
. . O

We PRP O
studied VBD O
a DT O
previously RB O
described VBN O
Swiss JJ O
family NN O
with IN O
inherited JJ B-Disease
C9 NNP I-Disease
deficiency NN I-Disease
. . O

BACKGROUND NNP O
Allelic NNP O
loss NN O
of IN O
chromosome NN O
18q CD O
predicts VBZ O
a DT O
poor JJ O
outcome NN O
in IN O
patients NNS O
with IN O
stage NN B-Disease
II NNP I-Disease
colorectal NN I-Disease
cancer NN I-Disease
. . O

This DT O
suggests VBZ O
that IN O
genomic JJ O
sequences NNS O
may MD O
play VB O
a DT O
critical JJ O
role NN O
in IN O
influencing VBG O
repeat NN O
instability NN O
. . O
. . O

A DT O
rapid JJ O
carrier NN O
detection NN O
assay RB O
detected VBD O
this DT O
mutation NN O
in IN O
three CD O
out IN O
of IN O
488 CD O
ATM NNP O
alleles NNS O
of IN O
Jewish JJ O
Moroccan NNP O
or CC O
Tunisian JJ O
origin NN O
. . O

However RB O
, , O
the DT O
function NN O
of IN O
the DT O
BRCA1 NNP O
protein NN O
has VBZ O
remained VBN O
elusive JJ O
. . O

The DT O
G230E NNP O
mutation NN O
causes VBZ O
substantial JJ O
changes NNS O
in IN O
anion NN O
and CC O
cation NN O
selectivity NN O
as RB O
well RB O
as IN O
a DT O
fundamental JJ O
change NN O
in IN O
rectification NN O
of IN O
the DT O
current JJ O
- : O
voltage NN O
relationship NN O
. . O

The DT O
size NN O
of IN O
the DT O
( ( O
CTG NNP O
) ) O
n RB O
repeat NN O
, , O
which WDT O
increases VBZ O
through IN O
generations NNS O
, , O
generally RB O
correlates VBZ O
with IN O
clinical JJ O
severity NN O
and CC O
age NN O
of IN O
onset NN O
. . O

A DT O
PCR NNP O
- : O
based VBN O
protocol NN O
is VBZ O
described VBN O
that IN O
was VBD O
used VBN O
to TO O
introduce VB O
mutations NNS O
in IN O
wild JJ O
- : O
type NN O
cDNA NN O
. . O

Subsequent JJ O
direct JJ O
sequencing NN O
of IN O
the DT O
target NN O
exons NNS O
identified VBN O
homozygous JJ O
mutations NNS O
in IN O
exon JJ O
16 CD O
of IN O
case NN O
1 CD O
and CC O
in IN O
exon JJ O
15 CD O
of IN O
case NN O
2 CD O
. . O

Inherited VBN O
mutant JJ O
alleles NNS O
of IN O
familial JJ O
tumour NN B-Disease
suppressor NN O
genes NNS O
predispose VBP O
individuals NNS O
to TO O
particular JJ O
types NNS O
of IN O
cancer NN B-Disease
. . O

The DT O
genomic JJ O
structure NN O
of IN O
the DT O
mouse NN O
WASP NNP O
gene NN O
is VBZ O
expressed VBN O
as IN O
an DT O
approximately RB O
2 CD O
. . O

Voltage NNP O
- : O
dependent NN O
blocks NNS O
by IN O
intracellular JJ O
and CC O
extracellular JJ O
iodide NN O
help NN O
to TO O
distinguish VB O
two CD O
distinct JJ O
ion NN O
binding VBG O
sites NNS O
within IN O
the DT O
hClC NN O
- : O
1 CD O
conduction NN O
pathway NN O
. . O

Ashkenazi NNP O
Jewish NNP O
population NN O
frequencies NNS O
for IN O
common JJ O
mutations NNS O
in IN O
BRCA1 NNP O
and CC O
BRCA2 NNP O
. . O

Canavan NNP B-Disease
disease NN I-Disease
is VBZ O
inherited VBN O
as IN O
an DT O
autosomal JJ O
recessive JJ O
trait NN O
that WDT O
is VBZ O
caused VBN O
by IN O
the DT O
deficiency NN B-Disease
of IN I-Disease
aspartoacylase NN I-Disease
( ( O
ASPA NNP O
) ) O
. . O

An DT O
intronic JJ O
mutation NN O
in IN O
a DT O
lariat JJ O
branchpoint NN O
sequence NN O
is VBZ O
a DT O
direct JJ O
cause NN O
of IN O
an DT O
inherited JJ B-Disease
human JJ I-Disease
disorder NN I-Disease
( ( O
fish JJ B-Disease
- : I-Disease
eye NN I-Disease
disease NN I-Disease
) ) O
. . O

In IN O
order NN O
to TO O
test VB O
this DT O
possibility NN O
we PRP O
have VBP O
analyzed VBN O
four CD O
heterozygotes NNS O
for IN O
class NN O
I PRP O
G6PD VBP O
mutations NNS O
two CD O
with IN O
G6PD NNP O
Portici NNP O
( ( O
1178G CD O
- : O
- : O
> VB O
A DT O
) ) O
and CC O
two CD O
with IN O
G6PD NNP O
Bari NNP O
( ( O
1187C CD O
- : O
- : O
> NN O
T NNP O
) ) O
. . O

Four CD O
novel JJ O
Swedish NNP O
founding NN O
mutations NNS O
were VBD O
identified VBN O
the DT O
nucleotide JJ O
2595 CD O
deletion NN O
A DT O
was VBD O
found VBN O
in IN O
five CD O
families NNS O
, , O
the DT O
C NNP O
1806 CD O
T NNP O
nonsense JJ O
mutation NN O
in IN O
three CD O
families NNS O
, , O
the DT O
3166 CD O
insertion NN O
TGAGA NNP O
in IN O
three CD O
families NNS O
, , O
and CC O
the DT O
nucleotide JJ O
1201 CD O
deletion NN O
11 CD O
in IN O
two CD O
families NNS O
. . O

The DT O
effect NN O
of IN O
altered JJ O
expression NN O
levels NNS O
of IN O
DMPK NNP O
, , O
which WDT O
is VBZ O
ubiquitously RB O
expressed VBN O
in IN O
all DT O
muscle NN O
cell NN O
lineages VBZ O
during IN O
development NN O
, , O
was VBD O
examined VBN O
by IN O
disrupting VBG O
the DT O
endogenous JJ O
Dmpk NNP O
gene NN O
and CC O
overexpressing VBG O
a DT O
normal JJ O
human JJ O
DMPK NNP O
transgene NN O
in IN O
mice NN O
. . O

The DT O
WASP NNP O
sequence NN O
contains VBZ O
two CD O
novel NN O
domains NNS O
that WDT O
are VBP O
homologous JJ O
to TO O
other JJ O
proteins NNS O
involved VBN O
in IN O
action NN O
organization NN O
. . O
. . O

When WRB O
LA NNP O
/ NNP O
D NNP O
and CC O
D NNP O
/ NNP O
D NNP O
GALT NNP O
biochemical JJ O
phenotypes NNS O
were VBD O
compared VBN O
to TO O
N NNP O
/ NNP O
N NNP O
GALT NNP O
phenotypes NNS O
, , O
both DT O
had VBD O
50 CD O
% NN O
, , O
as IN O
compared VBN O
to TO O
21 CD O
% NN O
, , O
reduction NN O
in IN O
GALT NNP O
activity NN O
in IN O
the DT O
wild JJ O
type NN O
( ( O
N NNP O
/ NNP O
N NNP O
) ) O
after IN O
exposure NN O
at IN O
identical JJ O
initial JJ O
enzyme NN O
activity NN O
to TO O
50 CD O
degrees NNS O
C NNP O
for IN O
15 CD O
min NN O
. . O

Identification NN O
of IN O
a DT O
RING NNP O
protein NN O
that WDT O
can MD O
interact VB O
in IN O
vivo NN O
with IN O
the DT O
BRCA1 NNP O
gene NN O
product NN O
. . O

Both DT O
genes NNS O
were VBD O
colocalized VBN O
to TO O
the DT O
C NNP O
- : O
D NNP O
band NN O
of IN O
mouse NN O
chromosome NN O
9 CD O
, , O
the DT O
proximal JJ O
end NN O
of IN O
q24 NN O
. . O

Each DT O
of IN O
the DT O
three CD O
patients NNS O
was VBD O
found VBN O
to TO O
be VB O
heterozygous JJ O
for IN O
a DT O
c862t JJ O
transition NN O
predicting VBG O
a DT O
R279W NNP O
substitution NN O
in IN O
the DT O
third JJ O
extracellular JJ O
loop NN O
of IN O
DTDST NNP O
. . O

Combined VBN B-Disease
subtotal JJ I-Disease
deficiency NN I-Disease
of IN I-Disease
C6 NNP I-Disease
and CC I-Disease
C7 NNP I-Disease
, , O
in IN O
which WDT O
both DT O
proteins NNS O
are VBP O
expressed VBN O
at IN O
very RB O
low JJ O
levels NNS O
, , O
has VBZ O
been VBN O
observed VBN O
in IN O
homozygous JJ O
form NN O
in IN O
two CD O
families NNS O
. . O

The DT O
type NN O
of IN O
genetic JJ O
variant NN O
was VBD O
determined VBN O
by IN O
molecular JJ O
analysis NN O
of IN O
DNA NNP O
, , O
extracted VBD O
from IN O
blood NN O
samples NNS O
. . O

Immunofluorescence NN O
microscopy NN O
showed VBD O
that IN O
emerin NN O
is VBZ O
located VBN O
at IN O
the DT O
nuclear JJ O
rim NN O
in IN O
all DT O
tissues NNS O
examined VBN O
. . O

Mapping NN O
of IN O
homozygous JJ O
deletions NNS O
on IN O
human JJ O
chromosome NN O
10q23 CD O
has VBZ O
led VBN O
to TO O
the DT O
isolation NN O
of IN O
a DT O
candidate NN O
tumor NN B-Disease
suppressor NN O
gene NN O
, , O
PTEN NNP O
, , O
that WDT O
appears VBZ O
to TO O
be VB O
mutated VBN O
at IN O
considerable JJ O
frequency NN O
in IN O
human JJ O
cancers NNS B-Disease
. . O

Our PRP$ O
results NNS O
show VBP O
that IN O
huntingtin NN O
is VBZ O
cleaved VBN O
by IN O
cysteine NN O
proteases NNS O
and CC O
suggest VBP O
that IN O
HD NNP B-Disease
might MD O
be VB O
a DT O
disorder NN B-Disease
of IN I-Disease
inappropriate JJ I-Disease
apoptosis NN I-Disease
. . O
. . O

Five CD O
were VBD O
splice NN O
site NN O
mutations NNS O
( ( O
one CD O
in IN O
the DT O
donor JJ O
site NN O
of IN O
intron NN O
4 CD O
, , O
two CD O
in IN O
the DT O
donor JJ O
site NN O
of IN O
intron NN O
6 CD O
, , O
one CD O
in IN O
each DT O
of IN O
the DT O
acceptor NN O
sites NNS O
of IN O
introns NNS O
8 CD O
and CC O
9 CD O
) ) O
and CC O
five CD O
were VBD O
nonsense JJ O
mutations NNS O
in IN O
exons NNS O
8 CD O
, , O
9 CD O
, , O
10 CD O
, , O
11 CD O
, , O
and CC O
12 CD O
. . O

Partial JJ O
sequences NNS O
of IN O
the DT O
1A1 CD O
- : O
3B CD O
B NNP O
- : O
box NN O
protein NN O
pseudogene NN O
and CC O
IFP NNP O
35 CD O
, , O
an DT O
interferon NN O
induced VBD O
leucine JJ O
zipper NN O
protein NN O
, , O
reside VB O
within IN O
the DT O
contig NN O
. . O

However RB O
, , O
both DT O
models NNS O
lack VBP O
other JJ O
frequent JJ O
DM NNP B-Disease
symptoms NNS O
including VBG O
the DT O
fibre NN O
- : O
type NN O
dependent JJ O
atrophy NN B-Disease
, , O
myotonia NN B-Disease
, , O
cataract NN B-Disease
and CC O
male JJ B-Disease
- : I-Disease
infertility NN I-Disease
. . O

5 CD O
of IN O
embryogenesis NN O
. . O

To TO O
test VB O
this DT O
proposition NN O
, , O
we PRP O
bred VBD O
HPRT NNP B-Disease
- : I-Disease
APRT NNP I-Disease
- : I-Disease
deficient NN I-Disease
mice NN O
. . O

CONCLUSION NNP O
. . O

Tumor NNP B-Disease
suppression NN O
and CC O
apoptosis NN O
of IN O
human JJ O
prostate NN B-Disease
carcinoma NN I-Disease
mediated VBN O
by IN O
a DT O
genetic JJ O
locus NN O
within IN O
human JJ O
chromosome NN O
10pter CD O
- : O
q11 NN O
. . O

This DT O
agrees VBZ O
well RB O
with IN O
the DT O
fact NN O
that IN O
cardiac NN O
and CC O
muscle NN O
symptoms NNS O
are VBP O
characteristic JJ O
for IN O
patients NNS O
with IN O
VLCAD NNP B-Disease
deficiency NN I-Disease
. . O

Variable JJ O
levels NNS O
of IN O
expression NN O
of IN O
Atm NNP O
were VBD O
observed VBN O
in IN O
different JJ O
tissues NNS O
. . O

Surprisingly RB O
, , O
mutations NNS O
in IN O
BRCA2 NNP O
are VBP O
infrequent JJ O
in IN O
cancers NNS B-Disease
including VBG O
breast NN B-Disease
carcinoma NN I-Disease
. . O

The DT O
cerebella NN O
of IN O
ATM NNP O
- : O
/ SYM O
- : O
mice NN O
appear IN O
normal JJ O
by IN O
histologic JJ O
examination NN O
at IN O
3 CD O
to TO O
4 CD O
months NNS O
and CC O
the DT O
mice NNS O
have VBP O
no DT O
gross JJ O
behavioral JJ B-Disease
abnormalities NNS I-Disease
. . O

Our PRP$ O
study NN O
indicates VBZ O
that IN O
chain NN O
- : O
terminating NN O
mutations NNS O
located VBN O
in IN O
the DT O
3 CD O
part NN O
of IN O
APC NNP B-Disease
do VBP O
not RB O
result VB O
in IN O
detectable JJ O
truncated JJ O
polypeptides NNS O
and CC O
we PRP O
hypothesize VBP O
that IN O
this DT O
is VBZ O
likely JJ O
to TO O
be VB O
the DT O
basis NN O
for IN O
the DT O
observed JJ O
AAPC NNP B-Disease
phenotype NN O
. . O
. . O

In IN O
addition NN O
, , O
we PRP O
have VBP O
detected VBN O
mutations NNS O
at IN O
codon NN O
51 CD O
in IN O
multiple JJ O
PCR NNP O
subclones NNS O
in IN O
two CD O
other JJ O
pancreatic JJ B-Disease
tumors NNS I-Disease
. . O

RESULTS NNP O
. . O

In IN O
stage NN B-Disease
II NNP I-Disease
colorectal NN I-Disease
carcinomas NN I-Disease
, , O
the DT O
absence NN O
of IN O
DCC NNP O
identifies VBZ O
a DT O
subgroup NN O
of IN O
patients NNS O
with IN O
lesions NNS O
that WDT O
behave VBP O
like IN O
stage NN B-Disease
III NNP I-Disease
cancers NNS I-Disease
. . O

It PRP O
differs VBZ O
from IN O
this DT O
and CC O
both DT O
the DT O
classical JJ O
and CC O
connatal JJ O
forms NNS O
of IN O
PMD NNP B-Disease
in IN O
that DT O
it PRP O
is VBZ O
relatively RB O
mild JJ O
in IN O
form NN O
, , O
onset NN O
is VBZ O
delayed VBN O
beyond IN O
age NN O
2 CD O
years NNS O
, , O
nystagmus NN B-Disease
is VBZ O
absent JJ O
, , O
tremors NNS B-Disease
are VBP O
prominent JJ O
, , O
mental JJ B-Disease
retardation NN I-Disease
is VBZ O
not RB O
severe JJ O
, , O
some DT O
patients NNS O
show VBP O
dementia JJ B-Disease
or CC O
personality NN B-Disease
disorders NNS I-Disease
, , O
the DT O
disease NN O
is VBZ O
progressive JJ O
rather RB O
than IN O
static JJ O
in IN O
some DT O
, , O
and CC O
several JJ O
females NNS O
show VBP O
signs NNS O
of IN O
disease NN O
. . O

The DT O
Fas NNP O
/ NNP O
Apo NNP O
- : O
1 CD O
receptor NN O
plays VBZ O
a DT O
crucial JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
apoptosis NN O
, , O
as IN O
demonstrated VBN O
by IN O
lymphoproliferation NN O
in IN O
MRL NNP O
- : O
lpr NN O
/ JJ O
lpr JJ O
mice NN O
and CC O
by IN O
the DT O
recently RB O
described VBN O
autoimmune JJ B-Disease
lymphoproliferative JJ I-Disease
syndrome NN I-Disease
( ( O
ALPS NNP B-Disease
) ) O
in IN O
humans NNS O
, , O
both DT O
of IN O
which WDT O
are VBP O
due JJ O
to TO O
mutations NNS O
in IN O
the DT O
Fas NNP O
gene NN O
. . O

The DT O
heterozygosity NN O
for IN O
876 CD O
deltaAGAA JJ O
mutation NN O
was VBD O
identified VBN O
in IN O
three CD O
independent JJ O
patients NNS O
from IN O
England NNP O
. . O

Among IN O
family NN O
members NNS O
, , O
an DT O
average JJ O
age NN O
of IN O
less JJR O
than IN O
55 CD O
years NNS O
at IN O
the DT O
diagnosis NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
, , O
the DT O
presence NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
, , O
the DT O
presence NN O
of IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
in IN O
the DT O
same JJ O
woman NN O
, , O
and CC O
Ashkenazi NNP O
Jewish NNP O
ancestry NN O
were VBD O
all DT O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
detecting VBG O
a DT O
BRCA1 NNP O
mutation NN O
. . O

The DT O
I66M NNP O
mutation NN O
in IN O
the DT O
wild JJ O
- : O
type NN O
GALC NNP O
cDNA NN O
( ( O
I289 NNP O
) ) O
had VBD O
normal JJ O
activity NN O
, , O
but CC O
when WRB O
this DT O
mutation NN O
and CC O
the DT O
V289 NNP O
polymorphism NN O
were VBD O
introduced VBN O
into IN O
the DT O
same JJ O
allele NN O
, , O
it PRP O
had VBD O
decreased VBN O
activity NN O
. . O

In IN O
order NN O
to TO O
investigate VB O
the DT O
role NN O
of IN O
CAG NNP O
expansion NN O
in IN O
the DT O
pathogenesis NN O
of IN O
HD NNP B-Disease
, , O
we PRP O
have VBP O
produced VBN O
transgenic JJ O
mice NN O
containing VBG O
the DT O
full JJ O
length NN O
human JJ O
HD NNP B-Disease
cDNA NN O
with IN O
44 CD O
CAG NNP O
repeats NNS O
. . O

These DT O
findings NNS O
help VBP O
to TO O
outline VB O
the DT O
relationship NN O
and CC O
evolution NN O
of IN O
mutations NNS O
in IN O
the DT O
human JJ O
G6PD NNP O
locus NN O
. . O
. . O

Strikingly RB O
, , O
mice NNS O
carrying VBG O
multiple JJ O
copies NNS O
on IN O
a DT O
wild JJ O
- : O
type NN O
background NN O
show NN O
specific JJ O
developmental JJ B-Disease
abnormalities NNS I-Disease
of IN I-Disease
the DT I-Disease
eye NN I-Disease
, , O
but CC O
not RB O
of IN O
other JJ O
tissues NNS O
expressing VBG O
the DT O
gene NN O
. . O

Analysis NN O
of IN O
the DT O
intragenic JJ O
polymorphism NN O
D17S855 NNP O
supports VBZ O
common JJ O
origins NNS O
of IN O
the DT O
mutations NNS O
. . O

One CD O
mutation NN O
, , O
a DT O
C NNP O
to TO O
A NNP O
exchange NN O
, , O
was VBD O
detected VBN O
in IN O
exon JJ O
2 CD O
at IN O
cDNA NN O
position NN O
166 CD O
, , O
the DT O
other JJ O
, , O
a DT O
C NNP O
to TO O
T NNP O
exchange NN O
, , O
was VBD O
located VBN O
in IN O
exon JJ O
4 CD O
( ( O
cDNA JJ O
position NN O
464 CD O
) ) O
. . O

Biochemical JJ O
fractionation NN O
of IN O
brain NN O
and CC O
liver NN O
tissues NNS O
showed VBD O
that IN O
emerin NN O
was VBD O
present JJ O
in IN O
nuclei JJ O
purified VBN O
by IN O
centrifugation NN O
through IN O
65 CD O
% NN O
sucrose NN O
and CC O
was VBD O
absent NN O
from IN O
soluble JJ O
fractions NNS O
( ( O
post NN O
- : O
100 CD O
, , O
0 CD O
g NN O
) ) O
. . O

Loss NNP O
of IN O
the DT O
wild JJ O
- : O
type NN O
allele NN O
in IN O
> JJ O
90 CD O
% NN O
of IN O
tumors NNS B-Disease
from IN O
patients NNS O
with IN O
inherited JJ O
BRCA1 NNP O
mutations NNS O
indicates VBZ O
tumor JJ B-Disease
suppressive JJ O
function NN O
. . O

Genetic JJ O
analysis NN O
of IN O
the DT O
family NN O
with IN O
two CD O
sibs NNS O
affected VBN O
by IN O
SJS NNP B-Disease
type NN I-Disease
2 CD I-Disease
showed VBD O
evidence NN O
against IN O
linkage NN O
to TO O
chromosome VB O
1p36 CD O
- : O
34 CD O
. . O

Each DT O
mutant JJ O
C2 NNP O
gene NN O
product NN O
is VBZ O
retained VBN O
early RB O
in IN O
the DT O
secretory JJ O
pathway NN O
. . O

Three CD O
different JJ O
vector NN O
systems NNS O
have VBP O
been VBN O
examined VBN O
. . O

In IN O
the DT O
first JJ O
family NN O
, , O
renal JJ B-Disease
lesions NNS I-Disease
were VBD O
present JJ O
in IN O
five CD O
out IN O
of IN O
six CD O
affected JJ O
individuals NNS O
, , O
whereas NNS O
HPT NNP B-Disease
and CC O
JT NNP B-Disease
were VBD O
seen VBN O
in IN O
four CD O
and CC O
two CD O
cases NNS O
, , O
respectively RB O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
demonstrate VBP O
that IN O
in IN O
addition NN O
to TO O
functional JJ O
alterations NNS O
these DT O
translocations NNS O
are VBP O
associated VBN O
with IN O
fusion NN O
product NN O
overexpression NN O
. . O

Together RB O
the DT O
data NN O
suggest NN O
that IN O
the DT O
MSH3 NNP O
gene NN O
encodes VBZ O
a DT O
product NN O
that WDT O
functions NNS O
in IN O
repair NN O
of IN O
some DT O
but CC O
not RB O
all DT O
pre SYM O
- : O
mutational JJ O
intermediates NNS O
, , O
its PRP$ O
mutation NN O
in IN O
tumours NNS B-Disease
can MD O
result VB O
in IN O
genomic JJ O
instability NN O
and CC O
, , O
as IN O
in IN O
yeast NN O
, , O
MSH3 NNP O
and CC O
MSH6 NNP O
are VBP O
partially RB O
redundant JJ O
for IN O
mismatch NN O
repair NN O
. . O
. . O

Association NNP O
studies NNS O
in IN O
two CD O
independent JJ O
samples NNS O
totaling VBG O
505 CD O
individuals NNS O
revealed VBD O
that IN O
the DT O
5 CD O
- : O
HTT NNP O
polymorphism NN O
accounts NNS O
for IN O
3 CD O
to TO O
4 CD O
percent NN O
of IN O
total JJ O
variation NN O
and CC O
7 CD O
to TO O
9 CD O
percent NN O
of IN O
inherited JJ O
variance NN O
in IN O
anxiety NN B-Disease
- : I-Disease
related JJ I-Disease
personality NN I-Disease
traits NNS I-Disease
in IN O
individuals NNS O
as RB O
well RB O
as IN O
sibships NNS O
. . O
. . O

To TO O
elucidate VB O
the DT O
role NN O
of IN O
DMPK NNP O
in IN O
DM NNP B-Disease
pathogenesis NN O
we PRP O
have VBP O
developed VBN O
Dmpk NNP B-Disease
deficient NN I-Disease
( ( O
Dmpk NNP O
- : O
/ SYM O
- : O
) ) O
mice NN O
. . O

Rather RB O
, , O
translation NN O
of IN O
the DT O
CAG NNP O
is VBZ O
crucial JJ O
for IN O
the DT O
pathogenesis NN O
of IN O
HD NNP B-Disease
. . O

Conformation NNP O
- : O
sensitive JJ O
gel NN O
electrophoresis NN O
and CC O
DNA NNP O
sequencing NN O
were VBD O
used VBN O
to TO O
identify VB O
BRCA1 NNP O
mutations NNS O
. . O

ATM NNP O
protein NN O
levels NNS O
and CC O
localization NN O
remain VBP O
constant JJ O
throughout IN O
all DT O
stages NNS O
of IN O
the DT O
cell NN O
cycle NN O
. . O

By IN O
analysis NN O
of IN O
these DT O
compiled VBN O
mutation NN O
data NNS O
, , O
we PRP O
demonstrated VBD O
clustering VBG O
of IN O
WASP NNP O
mutations NNS O
within IN O
the DT O
four CD O
most JJS O
N NNP O
- : O
terminal JJ O
exons NNS O
of IN O
the DT O
gene NN O
and CC O
also RB O
identified VBD O
several JJ O
sites NNS O
within IN O
this DT O
region NN O
as IN O
hotspots NNS O
for IN O
WASP NNP O
mutation NN O
. . O

Constitutively RB O
methylated VBN O
CpG NNP O
dinucleotides NNS O
as IN O
mutation NN O
hot JJ O
spots NNS O
in IN O
the DT O
retinoblastoma NN B-Disease
gene NN O
( ( O
RB1 NNP O
) ) O
. . O

In IN O
addition NN O
, , O
our PRP$ O
finding VBG O
illustrates VBZ O
the DT O
importance NN O
of IN O
this DT O
sequence NN O
for IN O
normal JJ O
human JJ O
mRNA NN O
processing NN O
. . O

Since IN O
patients NNS O
with IN O
between IN O
30 CD O
and CC O
40 CD O
repeats NNS O
are VBP O
rare JJ O
, , O
a DT O
consortium NN O
was VBD O
assembled VBN O
to TO O
collect VB O
such JJ O
individuals NNS O
. . O

These DT O
are VBP O
consecutive JJ O
, , O
population NN O
- : O
based VBN O
cases NNS O
not RB O
selected VBN O
for IN O
age NN O
or CC O
family NN O
history NN O
. . O

This DT O
suggests VBZ O
that IN O
mutations NNS O
within IN O
the DT O
3 CD O
- : O
terminal JJ O
region NN O
of IN O
the DT O
RB1 NNP O
gene NN O
may MD O
not RB O
be VB O
oncogenic JJ O
. . O

The DT O
detailed JJ O
case NN O
histories NNS O
of IN O
an DT O
exceptional JJ O
case NN O
from IN O
this DT O
series NN O
will MD O
be VB O
presented VBN O
a DT O
95 CD O
- : O
year NN O
- : O
old JJ O
man NN O
with IN O
39 CD O
repeats NNS O
who WP O
did VBD O
not RB O
have VB O
classical JJ O
features NNS O
of IN O
HD NNP B-Disease
. . O

Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome VBD I-Disease
protein NN O
, , O
a DT O
novel JJ O
effector NN O
for IN O
the DT O
GTPase NNP O
CDC42Hs NNP O
, , O
is VBZ O
implicated VBN O
in IN O
actin JJ O
polymerization NN O
. . O

The DT O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
( ( I-Disease
VHL NNP I-Disease
) ) I-Disease
disease NN I-Disease
product NN O
is VBZ O
thought VBN O
to TO O
down VB O
- : O
regulate NN O
transcription NN O
by IN O
antagonizing VBG O
elongin SYM O
- : O
enhanced JJ O
transcriptional JJ O
elongation NN O
. . O

Surprisingly RB O
, , O
investigation NN O
revealed VBD O
that IN O
the DT O
patients NNS O
complement NN O
was VBD O
normal JJ O
for IN O
all DT O
components NNS O
except IN O
C9 NNP O
, , O
which WDT O
was VBD O
functionally RB O
absent JJ O
. . O

ATM NNP O
is VBZ O
a DT O
member NN O
of IN O
the DT O
phosphatidylinositol NN O
- : O
3 CD O
- : O
kinase NN O
superfamily RB O
, , O
some DT O
of IN O
which WDT O
are VBP O
protein JJ O
kinases NNS O
and CC O
appear VBP O
to TO O
have VB O
important JJ O
roles NNS O
in IN O
cell NN O
cycle NN O
control NN O
and CC O
radiation NN O
signal JJ O
transduction NN O
. . O

The DT O
most RBS O
common JJ O
haplotypes NNS O
, , O
defined VBN O
by IN O
the DT O
alleles NNS O
Gln356Pro871Glu1038Ser1613 NNP O
and CC O
Gln356Leu871Gly1038Gly1613 NNP O
, , O
have VBP O
frequencies NNS O
of IN O
0 CD O
. . O

The DT O
homozygous JJ O
mutant NN O
( ( O
ATM NNP O
- : O
/ SYM O
- : O
) ) O
mice NN O
are VBP O
viable JJ O
, , O
growth NN O
- : O
retarded VBN O
, , O
and CC O
infertile NN O
. . O

Where WRB O
it PRP O
is VBZ O
combined VBN O
with IN O
a DT O
C6 NNP B-Disease
- : I-Disease
deficient NN I-Disease
gene NN O
, , O
the DT O
serum NN O
C7 NNP O
levels NNS O
can MD O
be VB O
surprisingly RB O
high JJ O
, , O
possibly RB O
because IN O
there EX O
is VBZ O
no DT O
C6 NNP O
generating VBG O
C56 NNP O
to TO O
consume VB O
the DT O
C7 NNP O
. . O

The DT O
BRCA2 NNP O
coding NN O
sequence NN O
is VBZ O
huge JJ O
, , O
composed VBN O
of IN O
26 CD O
exons NNS O
that IN O
span VBP O
10 CD O
, , O
443 CD O
bp NN O
. . O

Recurrent JJ O
transitions NNS O
were VBD O
observed VBN O
at IN O
most JJS O
of IN O
the DT O
14 CD O
codons NNS O
within IN O
the DT O
RB1 NNP O
. . O

Furthermore RB O
, , O
the DT O
broad JJ O
range NN O
of IN O
phenotypic NN O
severity NN O
observed VBN O
in IN O
these DT O
patients NNS O
raises VBZ O
the DT O
possibility NN O
that IN O
allelic JJ O
combination NN O
, , O
not RB O
just RB O
allelic JJ O
constitution NN O
, , O
may MD O
play VB O
some DT O
role NN O
in IN O
determining VBG O
outcome NN O
. . O

Ovarian JJ B-Disease
cancer NN I-Disease
risk NN O
in IN O
BRCA1 NNP O
carriers NNS O
is VBZ O
modified VBN O
by IN O
the DT O
HRAS1 NNP O
variable JJ O
number NN O
of IN O
tandem JJ O
repeat NN O
( ( O
VNTR NNP O
) ) O
locus NN O
. . O

In IN O
Drosophila NNP O
cells NNS O
, , O
cotransfected VBD O
VHL NNP O
represses NNS O
Sp1 NNP O
- : O
mediated VBN O
activation NN O
but CC O
not RB O
basal JJ O
activity NN O
of IN O
the DT O
VEGF NNP O
promoter NN O
. . O

About RB O
10 CD O
% NN O
of IN O
the DT O
homozygous JJ O
mutant NN O
animals NNS O
survived VBD O
to TO O
adulthood VB O
but CC O
have VB O
a DT O
much JJ O
shorter JJR O
life NN O
span NNS O
compared VBN O
with IN O
wild JJ O
- : O
type NN O
mice NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
pathogenesis NN O
of IN O
C7D NNP B-Disease
is VBZ O
heterogeneous JJ O
like IN O
most JJS O
of IN O
the DT O
other JJ O
deficiencies NNS B-Disease
of IN I-Disease
complement JJ I-Disease
components NNS I-Disease
. . O
. . O

This DT O
mutation NN O
has VBZ O
not RB O
been VBN O
found VBN O
so RB O
far RB O
in IN O
8 CD O
analyzed JJ O
ACG1B NNP B-Disease
patients NNS O
, , O
suggesting VBG O
that IN O
it PRP O
allows VBZ O
some DT O
residual JJ O
activity NN O
of IN O
the DT O
sulfate NN O
transporter NN O
. . O
. . O

GALT NNP O
protein VBD O
abundance NN O
was VBD O
increased VBN O
in IN O
LA NNP O
compared VBN O
to TO O
D NNP O
alleles NNS O
, , O
but CC O
mRNA NN O
was VBD O
similar JJ O
among IN O
all DT O
genotypes NNS O
. . O

A DT O
statistically RB O
significant JJ O
relationship NN O
was VBD O
found VBN O
in IN O
the DT O
activity NN O
of IN O
G6PD NNP O
between IN O
erythrocytes NNS O
and CC O
muscle NN O
of IN O
the DT O
male JJ O
subjects NNS O
( ( O
r VB O
= RB O
0 CD O
. . O
968 CD O
; : O
p NN O
= VBZ O
0 CD O
. . O
8 CD O
) ) O
. . O

A DT O
cell NN O
line NN O
has VBZ O
been VBN O
established VBN O
from IN O
the DT O
tumour NN B-Disease
of IN O
the DT O
proband NN O
and CC O
cytogenetic JJ O
and CC O
molecular JJ O
studies NNS O
carried VBD O
out RP O
, , O
providing VBG O
an DT O
extensive JJ O
analysis NN O
in IN O
this DT O
family NN O
. . O
. . O

The DT O
mutated JJ O
allele NN O
was VBD O
transmitted VBN O
through IN O
the DT O
mouse NN O
germ JJ O
line NN O
and CC O
homozygous JJ O
mutant NN O
animals NNS O
were VBD O
derived VBN O
from IN O
heterozygous JJ O
intercrosses NNS O
. . O

Four CD O
patients NNS O
also RB O
showed VBD O
rare JJ O
sequence NN O
variants NNS O
. . O

We PRP O
evaluated VBD O
GALT NNP O
enzyme JJ O
activity NN O
and CC O
screened VBD O
the DT O
GALT NNP O
genes NNS O
of IN O
145 CD O
patients NNS O
with IN O
one CD O
or CC O
more JJR O
N314D NNP O
- : O
containing NN O
alleles NNS O
. . O

Most JJS O
large JJ O
analyses NNS O
that WDT O
defined VBD O
the DT O
limits NNS O
of IN O
the DT O
normal JJ O
and CC O
pathological JJ O
size NN O
ranges VBZ O
employed VBN O
PCR NNP O
assays NNS O
, , O
which WDT O
included VBD O
the DT O
CAG NNP O
repeats NNS O
and CC O
a DT O
CCG NNP O
repeat NN O
tract NN O
that WDT O
was VBD O
thought VBN O
to TO O
be VB O
invariant JJ O
. . O

CONCLUSIONS NNP O
DCC NNP O
is VBZ O
a DT O
prognostic JJ O
marker NN O
in IN O
patients NNS O
with IN O
stage NN B-Disease
II NNP I-Disease
or CC I-Disease
stage NN I-Disease
III NNP I-Disease
colorectal JJ I-Disease
cancer NN I-Disease
. . O

The DT O
family NN O
does VBZ O
not RB O
appear VB O
to TO O
be VB O
remarkable JJ O
in IN O
the DT O
spectrum NN O
of IN O
tumours NNS B-Disease
, , O
and CC O
there EX O
is VBZ O
loss NN O
of IN O
the DT O
wild JJ O
- : O
type NN O
allele NN O
in IN O
a DT O
leiomyosarcoma NN B-Disease
from IN O
the DT O
proband NN O
. . O

We PRP O
have VBP O
identified VBN O
WASP NNP O
, , O
the DT O
protein NN O
that WDT O
is VBZ O
defective JJ O
in IN O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
, , O
as IN O
a DT O
novel JJ O
effector NN O
for IN O
CDC42Hs NNP O
, , O
but CC O
not RB O
for IN O
the DT O
other JJ O
Rho NNP O
family NN O
members NNS O
, , O
Rac NNP O
and CC O
Rho NNP O
. . O

Eight CD O
novel JJ O
candidate NN O
galactosemia NN B-Disease
mutations NNS O
were VBD O
found VBN O
. . O

The DT O
clinical JJ O
picture NN O
resembles VBZ O
somewhat RB O
that IN O
of IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
spastic JJ I-Disease
paraplegia NN I-Disease
( ( O
SPG NNP B-Disease
) ) O
. . O

The DT O
gene NN O
was VBD O
found VBN O
to TO O
span VB O
a DT O
genomic JJ O
region NN O
of IN O
over IN O
400 CD O
kb NNS O
. . O

In IN O
all DT O
three CD O
siblings NNS O
, , O
we PRP O
demonstrated VBD O
the DT O
presence NN O
of IN O
anergic JJ O
CD3 NNP O
+ NNP O
CD4 NNP O
- : O
CD8 NNP O
- : O
( ( O
double JJ O
negative JJ O
, , O
[ JJ O
DN NNP O
] NNP O
) ) O
T NNP O
cells NNS O
; : O
moreover RB O
, , O
a DT O
chronic JJ O
lymphocyte NN O
activation NN O
was VBD O
found VBN O
, , O
as IN O
demonstrated VBN O
by IN O
the DT O
presence NN O
of IN O
high JJ O
levels NNS O
of IN O
HLA NNP O
- : O
DR NNP O
expression NN O
on IN O
peripheral JJ O
CD3 NNP O
+ NNP O
cells NNS O
and CC O
by IN O
the DT O
presence NN O
of IN O
high JJ O
levels NNS O
of IN O
serum NN O
activation NN O
markers NNS O
such JJ O
as IN O
soluble JJ O
interleukin JJ O
- : O
2 CD O
receptor NN O
( ( O
slL JJ O
- : O
2R CD O
) ) O
and CC O
soluble JJ O
CD30 NNP O
( ( O
sCD30 NN O
) ) O
. . O
. . O

In IN O
most JJS O
people NNS O
with IN O
red JJ O
- : O
blood NN O
- : O
cell NN O
glucose JJ B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
, , O
the DT O
enzyme NN O
- : O
deficient NN O
phenotype NN O
is VBZ O
only RB O
moderately RB O
expressed VBN O
in IN O
nucleated JJ O
cells NNS O
. . O

In IN O
particular JJ O
, , O
a DT O
significant JJ O
proportion NN O
of IN O
disease NN O
- : O
causing NN O
mutations NNS O
results NNS O
in IN O
the DT O
premature JJ O
termination NN O
of IN O
protein JJ O
synthesis NN O
, , O
and CC O
the DT O
majority NN O
of IN O
these DT O
mutations NNS O
occur VBP O
as IN O
C NNP O
- : O
- : O
> NN O
T NNP O
transitions NNS O
at IN O
CpG NNP O
dinucleotides NNS O
( ( O
CpGs NNP O
) ) O
. . O

BRCA1 NNP O
and CC O
BRCA2 NNP O
are VBP O
the DT O
two CD O
major JJ O
identified VBN O
causes NNS O
of IN O
inherited JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
, , O
with IN O
mutations NNS O
in IN O
either DT O
gene NN O
conferring VBG O
up RP O
to TO O
80 CD O
- : O
90 CD O
% NN O
lifetime NN O
risk NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
in IN O
carrier NN O
females NNS O
. . O

Phenotypic NNP O
characterization NN O
of IN O
individuals NNS O
with IN O
30 CD O
- : O
40 CD O
CAG NNP O
repeats NNS O
in IN O
the DT O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
gene NN O
reveals NNS O
HD NNP B-Disease
cases NNS O
with IN O
36 CD O
repeats NNS O
and CC O
apparently RB O
normal JJ O
elderly JJ O
individuals NNS O
with IN O
36 CD O
- : O
39 CD O
repeats NNS O
. . O

Although IN O
this DT O
microsatellite JJ B-Disease
instability NN I-Disease
has VBZ O
been VBN O
attributed VBN O
to TO O
mutations NNS O
in IN O
four CD O
DNA NNP O
mismatch NN O
repair NN O
genes NNS O
in IN O
hereditary JJ B-Disease
nonpolyposis NN I-Disease
colorectal NN I-Disease
cancer NN I-Disease
( ( O
HNPCC NNP B-Disease
) ) O
kindreds NNS O
, , O
many JJ O
sporadic JJ B-Disease
tumours NNS I-Disease
exhibit VBP O
instability NN O
but CC O
no DT O
detectable JJ O
mutations NNS O
in IN O
these DT O
genes NNS O
. . O

The DT O
gene NN O
mutated VBN O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
AT NNP B-Disease
) ) O
patients NNS O
, , O
denoted VBN O
ATM NNP O
, , O
encodes VBZ O
a DT O
putative JJ O
protein NN O
or CC O
lipid JJ O
kinase NN O
. . O

Colchicine NN O
was VBD O
found VBN O
to TO O
be VB O
excreted VBN O
in IN O
breast NN O
milk NN O
. . O

The DT O
PAX3 NNP O
- : O
FKHR NNP O
fusion NN O
product NN O
retains VBZ O
the DT O
DNA NN O
binding VBG O
domains NNS O
of IN O
the DT O
PAX3 NNP O
protein NN O
and CC O
the DT O
putative JJ O
activator NN O
domain NN O
of IN O
the DT O
FKHR NNP O
protein NN O
. . O

We PRP O
identified VBD O
a DT O
frameshift JJ O
mutation NN O
in IN O
the DT O
3 CD O
part NN O
of IN O
exon NN O
15 CD O
, , O
resulting VBG O
in IN O
a DT O
stop JJ O
codon NN O
at IN O
1862 CD O
, , O
in IN O
a DT O
large JJ O
Dutch NN O
kindred VBD O
with IN O
AAPC NNP B-Disease
. . O

An DT O
extended JJ O
homology NN O
search NN O
revealed VBD O
a DT O
distant JJ O
relationship NN O
of IN O
this DT O
stretch NN O
to TO O
the DT O
vasodilator NN O
- : O
stimulated VBN O
phosphoprotein NN O
( ( O
VASP NNP O
) ) O
, , O
which WDT O
is VBZ O
involved VBN O
in IN O
the DT O
maintenance NN O
of IN O
cyto NN O
- : O
architecture NN O
by IN O
interacting VBG O
with IN O
actin JJ O
- : O
like IN O
filaments NNS O
. . O
. . O

In IN O
the DT O
diagnostic JJ O
setting NN O
it PRP O
is VBZ O
necessary JJ O
to TO O
define VB O
the DT O
limits NNS O
of IN O
the DT O
CAG NNP O
size NN O
ranges VBZ O
on IN O
normal JJ O
and CC O
HD NNP B-Disease
- : O
associated VBN O
chromosomes NNS O
. . O

The DT O
findings NNS O
suggest VBP O
that IN O
both DT O
HDL NNP O
concentration NN O
and CC O
the DT O
dynamics NNS O
of IN O
cholesterol NN O
transport NN O
through IN O
HDL NNP O
( ( O
i NN O
. . O
e NN O
. . O
, , O
reverse VB O
cholesterol NN O
transport NN O
) ) O
determine VBZ O
the DT O
anti JJ O
- : O
atherogenicity NN O
of IN O
the DT O
HDL NNP O
fraction NN O
. . O

More JJR O
than IN O
85 CD O
% NN O
of IN O
all DT O
known VBN O
missense NN O
mutations NNS O
were VBD O
localized VBN O
in IN O
the DT O
amino NN O
- : O
terminal JJ O
stretch NN O
of IN O
the DT O
WASP NNP O
gene NN O
product NN O
; : O
this DT O
region NN O
contained VBD O
a DT O
mutational JJ O
hot JJ O
spot NN O
at IN O
codon NN O
86 CD O
. . O

Seven NNP O
HD NNP B-Disease
patients NNS O
had VBD O
36 CD O
repeats NNS O
, , O
which WDT O
confirms VBZ O
that IN O
this DT O
allele NN O
is VBZ O
associated VBN O
with IN O
disease NN O
. . O

However RB O
, , O
it PRP O
is VBZ O
not RB O
yet RB O
clear JJ O
what WP O
proportion NN O
of IN O
hereditary JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
is VBZ O
explained VBN O
by IN O
BRCA1 NNP O
and CC O
BRCA2 NNP O
or CC O
by IN O
some DT O
other JJ O
unidentified JJ O
susceptibility NN O
gene NN O
( ( O
s JJ O
) ) O
. . O

The DT O
deduced JJ O
codon NN O
sequence NN O
of IN O
three CD O
peptides NNS O
was VBD O
used VBN O
to TO O
derive VB O
degenerated JJ O
oligomeres NNS O
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
associated VBN O
with IN O
the DT O
expansion NN O
of IN O
a DT O
( ( O
CTG NNP O
) ) O
n FW O
trinucleotide JJ O
repeat NN O
in IN O
the DT O
3 CD O
untranslated JJ O
region NN O
( ( O
UTR NNP O
) ) O
of IN O
the DT O
DM NNP B-Disease
protein NN O
kinase NN O
gene NN O
( ( O
DMPK NNP O
) ) O
. . O

AO NNP B-Disease
- : I-Disease
GLD NNP I-Disease
mutations NNS O
, , O
including VBG O
those DT O
found VBN O
here RB O
, , O
are VBP O
located VBN O
in IN O
the DT O
N NNP O
- : O
terminus NN O
( ( O
I66M NNP O
, , O
G270D NNP O
, , O
535 CD O
- : O
573del CD O
) ) O
or CC O
C NNP O
- : O
terminus NN O
( ( O
L618S NNP O
) ) O
of IN O
the DT O
GALC NNP O
enzyme NN O
, , O
whereas IN O
the DT O
reported JJ O
mutations NNS O
in IN O
the DT O
infantile JJ O
form NN O
( ( O
IF NNP B-Disease
- : I-Disease
GLD NN I-Disease
) ) O
are VBP O
in IN O
the DT O
central JJ O
domain NN O
. . O

The DT O
nucleotide JJ O
sequence NN O
obtained VBN O
from IN O
the DT O
genomic JJ O
regions NNS O
adjacent VBP O
to TO O
the DT O
exon NN O
boundaries NNS O
enabled VBD O
us PRP O
to TO O
develop VB O
a DT O
set NN O
of IN O
primer NN O
pairs NNS O
for IN O
PCR NNP O
amplification NN O
of IN O
the DT O
complete JJ O
coding NN O
region NN O
. . O

Common JJ O
BRCA1 NNP O
variants NNS O
and CC O
susceptibility NN O
to TO O
breast VB B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
in IN O
the DT O
general JJ O
population NN O
. . O

Myotonic NNP B-Disease
dystrophy NN I-Disease
, , O
or CC O
dystrophia NN B-Disease
myotonica NN I-Disease
( ( O
DM NNP B-Disease
) ) O
, , O
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
multisystem NN I-Disease
disorder NN I-Disease
caused VBN O
by IN O
the DT O
expansion NN O
of IN O
a DT O
CTG NNP O
trinucleotide NN O
repeat NN O
in IN O
the DT O
3 CD O
untranslated JJ O
region NN O
of IN O
the DT O
DMPK NNP O
protein NN O
kinase VBD O
gene NN O
on IN O
chromosome NN O
19q13 CD O
. . O

We PRP O
have VBP O
generated VBN O
a DT O
mouse NN O
model NN O
for IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
by IN O
using VBG O
gene NN O
targeting VBG O
to TO O
generate VB O
mice NN O
that WDT O
do VBP O
not RB O
express VB O
the DT O
Atm NNP O
protein NN O
. . O

Muscle NNP O
expression NN O
of IN O
glucose JJ B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
deficiency NN I-Disease
in IN O
different JJ O
variants NNS O
. . O

Atm NNP O
, , O
the DT O
mouse NN O
homolog NN O
of IN O
the DT O
human JJ O
ATM NNP O
gene NN O
defective NN O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
, , O
has VBZ O
been VBN O
identified VBN O
. . O

Mutation NN O
analysis NN O
in IN O
19 CD O
families NNS O
of IN O
German JJ O
, , O
Swiss JJ O
and CC O
Turkish JJ O
descent NN O
by IN O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
and CC O
sequencing NN O
resulted VBD O
in IN O
the DT O
detection NN O
of IN O
seven CD O
novel NNS O
and CC O
10 CD O
known VBN O
mutations NNS O
. . O

Using VBG O
statistical JJ O
models NNS O
specifically RB O
designed VBN O
to TO O
study VB O
single JJ O
- : O
sperm JJ O
segregation NN O
data NNS O
, , O
we PRP O
find VBP O
no DT O
evidence NN O
of IN O
meiotic JJ O
segregation NN O
distortion NN O
. . O

The DT O
vast JJ O
majority NN O
of IN O
both DT O
polymorphic JJ O
and CC O
sporadic JJ O
G6PD NNP O
variants NNS O
are VBP O
due JJ O
to TO O
single JJ O
missense NN O
mutations NNS O
. . O

1 CD O
of IN O
rat NN O
chromosome NN O
8 CD O
, , O
and CC O
qa4 SYM O
- : O
qa5 NN O
of IN O
Syrian JJ O
hamster NN O
chromosome NN O
12 CD O
. . O

Furthermore RB O
, , O
the DT O
cation NN O
- : O
to TO O
- : O
anion NN O
permeability NN O
ratio NN O
of IN O
the DT O
mutant NN O
is VBZ O
much RB O
greater JJR O
than IN O
that DT O
of IN O
the DT O
wild JJ O
- : O
type NN O
channel NN O
. . O

Type NNP B-Disease
II NNP I-Disease
complement NN I-Disease
protein NN I-Disease
C2 NNP I-Disease
deficiency NN I-Disease
is VBZ O
characterized VBN O
by IN O
a DT O
selective JJ O
block NN O
in IN O
C2 NNP O
secretion NN O
. . O

Absence NN O
of IN O
disease NN O
phenotype NN O
and CC O
intergenerational JJ O
stability NN O
of IN O
the DT O
CAG NNP O
repeat NN O
in IN O
transgenic JJ O
mice NN O
expressing VBG O
the DT O
human JJ O
Huntington NNP B-Disease
disease NN I-Disease
transcript NN O
. . O

No DT O
region NN O
of IN O
the DT O
RB1 NNP O
gene NN O
was VBD O
preferentially RB O
involved VBN O
in IN O
single JJ O
base NN O
substitutions NNS O
. . O

The DT O
most RBS O
common JJ O
variant NN O
of IN O
GALT NNP O
, , O
the DT O
Duarte NNP O
variant NN O
, , O
occurs VBZ O
as IN O
two CD O
types NNS O
, , O
Duarte NNP O
- : O
1 CD O
( ( O
D NNP O
- : O
1 CD O
) ) O
and CC O
Duarte NNP O
- : O
2 CD O
( ( O
D NNP O
- : O
2 CD O
) ) O
, , O
both DT O
of IN O
which WDT O
carry VBP O
the DT O
sequence NN O
change NN O
N314D NNP O
. . O

However RB O
, , O
these DT O
findings NNS O
suggest VBP O
that IN O
PKU NNP B-Disease
can MD O
be VB O
completely RB O
corrected VBN O
by IN O
somatic JJ O
gene NN O
therapy NN O
, , O
and CC O
provide VB O
some DT O
direction NN O
for IN O
the DT O
future NN O
development NN O
of IN O
adenoviral JJ O
vectors NNS O
. . O
. . O

However RB O
, , O
one CD O
individual NN O
is VBZ O
heterozygous JJ O
for IN O
markers NNS O
at IN O
adjacent JJ O
C6 NNP O
loci NN O
, , O
showing VBG O
that IN O
there EX O
has VBZ O
been VBN O
an DT O
intergenic JJ O
recombination NN O
and CC O
suggesting VBG O
that IN O
the DT O
deficiency NN O
mutation NN O
is VBZ O
of IN O
appreciable JJ O
antiquity NN O
. . O
. . O

The DT O
entire JJ O
coding NN O
sequence NN O
of IN O
the DT O
Atm NNP O
transcript NN O
was VBD O
cloned VBN O
and CC O
found VBN O
to TO O
contain VB O
an DT O
open JJ O
reading NN O
frame NN O
encoding VBG O
a DT O
protein NN O
of IN O
3066 CD O
amino NN O
acids NNS O
with IN O
84 CD O
% NN O
overall JJ O
identity NN O
and CC O
91 CD O
% NN O
similarity NN O
to TO O
the DT O
human JJ O
ATM NNP O
protein NN O
. . O

Missense JJ O
mutations NNS O
in IN O
the DT O
Fas NNP O
gene NN O
resulting VBG O
in IN O
autoimmune JJ B-Disease
lymphoproliferative JJ I-Disease
syndrome NN I-Disease
: : O
a DT O
molecular JJ O
and CC O
immunological JJ O
analysis NN O
. . O

The DT O
positioning NN O
of IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
primers NNS O
was VBD O
such JJ O
that IN O
the DT O
resulting VBG O
PCR NNP O
products NNS O
were VBD O
of IN O
different JJ O
sizes NNS O
, , O
which WDT O
enabled VBD O
us PRP O
to TO O
analyze VB O
two CD O
different JJ O
exons NNS O
simultaneously RB O
and CC O
still RB O
distinguish VB O
between IN O
the DT O
banding NN O
profiles NNS O
for IN O
both DT O
( ( O
biplex JJ O
analysis NN O
) ) O
. . O

To TO O
determine VB O
the DT O
molecular JJ O
basis NN O
of IN O
Type NNP B-Disease
II NNP I-Disease
deficiency VBZ I-Disease
the DT O
two CD O
Type NNP O
II NNP O
C2Q0 NNP O
genes NNS O
were VBD O
isolated VBN O
and CC O
transfected VBN O
separately RB O
into IN O
L NNP O
- : O
cells NNS O
. . O

Type NNP O
III NNP O
collagen NN O
is VBZ O
crucial JJ O
for IN O
collagen NN O
I PRP O
fibrillogenesis VBP O
and CC O
for IN O
normal JJ O
cardiovascular JJ O
development NN O
. . O

Adult NNP B-Disease
onset MD I-Disease
globoid VB I-Disease
cell NN I-Disease
leukodystrophy NN I-Disease
( ( O
Krabbe NNP B-Disease
disease NN I-Disease
) ) O
: : O
analysis NN O
of IN O
galactosylceramidase NN O
cDNA NN O
from IN O
four CD O
Japanese JJ O
patients NNS O
. . O

RESULTS NNP O
BRCA1 NNP O
mutations NNS O
were VBD O
identified VBN O
in IN O
16 CD O
percent NN O
of IN O
women NNS O
with IN O
a DT O
family NN O
history NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
. . O

Reduced VBN O
incorporation NN O
of IN O
inorganic JJ O
sulfate NN O
into IN O
macromolecules NNS O
was VBD O
found VBN O
in IN O
all DT O
three CD O
. . O

In IN O
keeping VBG O
with IN O
the DT O
nature NN O
of IN O
this DT O
mutation NN O
, , O
various JJ O
antibodies NNS O
directed VBN O
against IN O
the DT O
ATM NNP O
protein NN O
failed VBD O
to TO O
defect VB O
this DT O
protein NN O
in IN O
patient JJ O
cells NNS O
. . O

Atm NNP O
, , O
Acat1 NNP O
, , O
and CC O
Npat NNP O
, , O
which WDT O
is VBZ O
a DT O
new JJ O
gene NN O
isolated VBN O
from IN O
the DT O
AT NNP O
region NN O
, , O
and CC O
12 CD O
flanking VBG O
microsatellite JJ O
DNA NN O
markers NNS O
were VBD O
examined VBN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
Gly NNP O
230 CD O
is VBZ O
critical JJ O
for IN O
normal JJ O
ion NN O
conductance NN O
in IN O
hClC JJ O
- : O
1 CD O
and CC O
that IN O
this DT O
residue JJ O
resides NNS O
within IN O
the DT O
channel NN O
pore NN O
. . O
. . O

VEGF NNP O
promoter NN O
- : O
luciferase NN O
constructs NNS O
were VBD O
transiently RB O
cotransfected VBN O
with IN O
a DT O
wild JJ O
- : O
type NN O
VHL NNP O
( ( O
wt SYM O
- : O
VHL NN O
) ) O
vector NN O
in IN O
several JJ O
cell NN O
lines NNS O
, , O
including VBG O
293 CD O
embryonic JJ O
kidney NN O
and CC O
RCC NNP B-Disease
cell NN O
lines NNS O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
frequency NN O
of IN O
four CD O
of IN O
these DT O
polymorphisms NNS O
Gln356Arg NNP O
, , O
Pro871Leu NNP O
, , O
Glu1038Gly NNP O
and CC O
Ser1613Gly NNP O
in IN O
large JJ O
series NN O
of IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
cases NNS O
and CC O
matched JJ O
controls NNS O
. . O

Only RB O
7 CD O
percent NN O
of IN O
women NNS O
from IN O
families NNS O
with IN O
a DT O
history NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
but CC O
not RB O
ovarian JJ B-Disease
cancer NN I-Disease
had VBD O
BRCA1 NNP O
mutations NNS O
. . O

2 CD O
, , O
a DT O
region NN O
proposed VBN O
to TO O
contain VB O
tumor NN B-Disease
suppressor NN O
gene NN O
( ( O
s PRP O
) ) O
, , O
is VBZ O
mutated VBN O
at IN O
high JJ O
frequency NN O
in IN O
human JJ O
breast NN B-Disease
cancer NN I-Disease
. . O

The DT O
children NNS O
share NN O
common JJ O
clinical JJ O
features NNS O
including VBG O
splenomegaly NN B-Disease
and CC O
lymphadenopathy JJ B-Disease
, , O
but CC O
only RB O
one CD O
developed VBD O
severe JJ O
autoimmune JJ B-Disease
manifestations NNS I-Disease
. . O

For IN O
RT NNP O
- : O
PCR NN O
products NNS O
, , O
only RB O
the DT O
translated JJ O
portion NN O
of IN O
the DT O
gene NN O
was VBD O
screened VBN O
. . O

A DT O
fragment NN O
of IN O
200 CD O
b NN O
was VBD O
cloned VBN O
and CC O
used VBN O
as IN O
a DT O
probe NN O
to TO O
screen VB O
a DT O
mouse NN O
liver NN O
cDNA NN O
library NN O
. . O

DNA NN O
sequencing NN O
of IN O
the DT O
exon JJ O
- : O
intron NN O
junctions NNS O
revealed VBD O
a DT O
number NN O
of IN O
revisions NNS O
regarding VBG O
the DT O
boundaries NNS O
between IN O
exons NNS O
4 CD O
, , O
5 CD O
, , O
and CC O
6 CD O
as RB O
well RB O
as IN O
between IN O
exons NNS O
10 CD O
and CC O
11 CD O
. . O

To TO O
study VB O
the DT O
interactions NNS O
of IN O
these DT O
two CD O
genes NNS O
on IN O
an DT O
organismal JJ O
level NN O
, , O
we PRP O
bred VBD O
mice RB O
heterozygous JJ O
for IN O
null JJ O
alleles NNS O
of IN O
both DT O
atm NNS O
and CC O
p53 NN O
to TO O
produce VB O
all DT O
genotypic NN O
combinations NNS O
. . O

We PRP O
show VBP O
that IN O
this DT O
region NN O
of IN O
the DT O
genome NN O
contains VBZ O
a DT O
tandem JJ O
duplication NN O
of IN O
approximately RB O
30 CD O
kilobases NNS O
, , O
which WDT O
results NNS O
in IN O
two CD O
copies NNS O
of IN O
BRCA1 NNP O
exons NNS O
1 CD O
and CC O
2 CD O
, , O
of IN O
exons NNS O
1 CD O
and CC O
3 CD O
of IN O
the DT O
adjacent JJ O
1A1 CD O
- : O
3B CD O
gene NN O
and CC O
of IN O
the DT O
previously RB O
reported VBN O
295 CD O
base NN O
pair NN O
intergenic JJ O
region NN O
. . O

Eleven NNP O
of IN O
the DT O
15 CD O
kindreds NNS O
manifesting VBG O
BRCA1 NNP O
mutations NNS O
were VBD O
breast SYM B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
, , O
several JJ O
of IN O
them PRP O
with IN O
a DT O
predominant JJ O
ovarian JJ B-Disease
cancer NN I-Disease
phenotype NN O
. . O

The DT O
possibility NN O
of IN O
the DT O
latter JJ O
cosegregating NN O
as IN O
a DT O
separate JJ O
autosomal JJ O
dominant JJ O
gene NN O
can MD O
not RB O
be VB O
ruled VBN O
out RP O
. . O

OBJECTIVE NNP O
. . O

Mutations NNS O
detected VBN O
in IN O
two CD O
of IN O
four CD O
of IN O
these DT O
are VBP O
missense JJ O
mutations NNS O
, , O
normally RB O
rare JJ O
in IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
. . O

Alignment NN O
of IN O
the DT O
predicted VBN O
amino NN O
acid JJ O
sequence NN O
of IN O
human JJ O
VLCAD NNP O
with IN O
those DT O
of IN O
the DT O
other JJ O
human JJ O
ACD NNP O
enzymes NNS O
revealed VBD O
extensive JJ O
sequence NN O
homology NN O
. . O

A DT O
mutation NN O
in IN O
autosomal JJ B-Disease
dominant JJ I-Disease
myotonia NN I-Disease
congenita NN I-Disease
affects VBZ O
pore IN O
properties NNS O
of IN O
the DT O
muscle NN O
chloride NN O
channel NN O
. . O

The DT O
eight CD O
novel NN O
mutations NNS O
identified VBD O
included VBD O
1 CD O
- : O
and CC O
4 CD O
- : O
bp NN O
deletions NNS O
( ( O
32 CD O
deltaT NN O
and CC O
876 CD O
deltaAGAA NN O
, , O
respectively RB O
) ) O
and CC O
I16T NNP O
, , O
G27R NNP O
, , O
D114E NNP O
, , O
G123E NNP O
, , O
C152Y NNP O
, , O
and CC O
R168C NNP O
missense NN O
mutations NNS O
. . O

To TO O
begin VB O
to TO O
address VB O
the DT O
hypothesis NN O
that WDT O
abnormal JJ O
regulation NN O
of IN O
the DT O
breast NN B-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
gene NN O
BRCA1 NNP O
is VBZ O
a DT O
critical JJ O
step NN O
in IN O
sporadic JJ O
breast NN O
/ NNP O
ovarian JJ O
tumorigenesis NN O
, , O
we PRP O
have VBP O
determined VBN O
the DT O
detailed JJ O
structure NN O
of IN O
the DT O
BRCA1 NNP O
genomic JJ O
region NN O
. . O

Twelve NNP O
aniridia NN B-Disease
patients NNS O
, , O
five CD O
with IN O
a DT O
family NN O
history NN O
and CC O
seven CD O
presumed VBD O
to TO O
be VB O
sporadic JJ O
, , O
were VBD O
exhaustively RB O
screened VBN O
in IN O
order NN O
to TO O
test VB O
what WP O
proportion NN O
of IN O
people NNS O
with IN O
aniridia NN B-Disease
, , O
uncomplicated VBN O
by IN O
associated JJ O
anomalies NNS O
, , O
carry VBP O
mutations NNS O
in IN O
the DT O
human JJ O
PAX6 NNP O
gene NN O
. . O

Also RB O
the DT O
delta NN O
c418 NN O
allele NN O
was VBD O
underrepresented VBN O
in IN O
the DT O
cDNA NN O
, , O
in IN O
accordance NN O
with IN O
previous JJ O
observations NNS O
that IN O
premature NN O
stop VB O
codons NNS O
reduce VB O
mRNA NN O
levels NNS O
. . O

Detection NN O
of IN O
heterozygous JJ O
mutations NNS O
in IN O
BRCA1 NNP O
using VBG O
high JJ O
density NN O
oligonucleotide VBP O
arrays NNS O
and CC O
two CD O
- : O
colour NN O
fluorescence NN O
analysis NN O
. . O

If IN O
this DT O
finding NN O
can MD O
be VB O
confirmed VBN O
, , O
it PRP O
may MD O
provide VB O
an DT O
insight NN O
into IN O
the DT O
structural JJ O
features NNS O
of IN O
the DT O
BRCA1 NNP O
protein NN O
that WDT O
are VBP O
important JJ O
for IN O
its PRP$ O
function NN O
. . O

The DT O
spectrum NN O
of IN O
RB1 NNP O
germ FW O
- : O
line NN O
mutations NNS O
in IN O
hereditary JJ B-Disease
retinoblastoma NN I-Disease
. . O

ATM NNP O
- : O
/ SYM O
- : O
fibroblasts NNS O
are VBP O
inefficient JJ O
in IN O
G1 NNP O
to TO O
S NNP O
- : O
phase NN O
progression NN O
following VBG O
serum JJ O
stimulation NN O
and CC O
senesce NN O
after IN O
only RB O
a DT O
few JJ O
passages NNS O
in IN O
culture NN O
. . O

However RB O
, , O
these DT O
mutations NNS O
are VBP O
uncommon JJ O
in IN O
the DT O
population NN O
and CC O
they PRP O
probably RB O
account VBP O
for IN O
only RB O
a DT O
few JJ O
percent NN O
of IN O
all DT O
breast NN B-Disease
cancer NN I-Disease
incidence NN O
. . O

Germ NNP O
- : O
line NN O
mutations NNS O
of IN O
the DT O
BRCA1 NNP O
gene NN O
are VBP O
responsible JJ O
for IN O
a DT O
substantial JJ O
proportion NN O
of IN O
families NNS O
with IN O
multiple JJ O
cases NNS O
of IN O
early JJ O
- : O
onset NN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

Ataxia NNP B-Disease
- : I-Disease
telangiectasia NN I-Disease
: : O
founder NN O
effect NN O
among IN O
north JJ O
African JJ O
Jews NNP O
. . O

We PRP O
describe VBP O
herein RB O
, , O
to TO O
our PRP$ O
knowledge NN O
, , O
for IN O
the DT O
first JJ O
time NN O
, , O
the DT O
cloning NN O
of IN O
a DT O
full JJ O
- : O
length NN O
cDNA NN O
for IN O
ATM NNP O
and CC O
correction NN O
of IN O
multiple JJ O
aspects NNS O
of IN O
the DT O
radio NN O
- : O
sensitive JJ O
phenotype NN O
of IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
cells NNS O
by IN O
transfection NN O
with IN O
this DT O
cDNA NN O
. . O

The DT O
short JJ O
variant NN O
of IN O
the DT O
polymorphism NN O
reduces VBZ O
the DT O
transcriptional JJ O
efficiency NN O
of IN O
the DT O
5 CD O
- : O
HTT NNP O
gene NN O
promoter NN O
, , O
resulting VBG O
in IN O
decreased JJ O
5 CD O
- : O
HTT NNP O
expression NN O
and CC O
5 CD O
- : O
HT NNP O
uptake VBP O
in IN O
lymphoblasts NNS O
. . O

We PRP O
have VBP O
determined VBN O
the DT O
genomic JJ O
organization NN O
of IN O
CHRNA4 NNP O
, , O
which WDT O
consists VBZ O
of IN O
six CD O
exons NNS O
distributed VBN O
over IN O
approximately RB O
17 CD O
kb NNS O
of IN O
genomic JJ O
DNA NNP O
. . O

The DT O
cDNA NN O
encodes VBZ O
for IN O
a DT O
protein NN O
of IN O
50 CD O
kDa NNS O
, , O
as IN O
predicted VBN O
. . O

In IN O
the DT O
Japanese JJ O
population NN O
, , O
however RB O
, , O
there EX O
has VBZ O
been VBN O
no DT O
report NN O
demonstrating VBG O
the DT O
contribution NN O
of IN O
IDDM2 NNP O
to TO O
the DT O
pathogenesis NN O
of IN O
IDDM NNP B-Disease
. . O

